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Elevated blood cholesterol is a major risk factor for cardiovascular disease 
(CVD). Cholesterol accumulates in the arteries, restricting blood flow and raising 
blood pressure. Blood total cholesterol (TC) and low-density lipoprotein 
cholesterol (LDLC) correlates directly with the risk of heart diseases, whereas 
high-density lipoprotein cholesterol (HDLC) correlates inversely with the risk. 
Tartary buckwheat has become a popular functional food in many countries. 
Tartary buckwheat grains are rich in functional components such as phytosterol 
and flavonoids which may contribute to lower blood cholesterol. The protein 
component of common buckwheat was demonstrated to lower the plasma 
cholesterol. Considering that Tartary buckwheat has similar composition to 
common buckwheat, the question arises that if Tartary buckwheat has the same 
effect on the blood cholesterol profile. Although some studies have found 
buckwheat is hypolipidemic, there is no study eluding the mechanism in 
molecular level. This research is therefore to use hamsters as an animal model to 
investigate 1 ) the hypocholesterolemic activity of Tartary buckwheat flour 
compared with wheat and rice flours; 2) the hypocholesterolemic activity of 
defatted Tartary buckwheat protein compared with wheat gluten and rice protein 
extract; 3) the underlying molecular mechanism of this hypocholesterolemic 
activity. 
Golden hamsters were given 0.1% of dietary cholesterol and 5% of lard to 
induce high blood cholesterol level. In the first study, Tartary buckwheat flour, 
wheat flour and rice flour were added in the diet to provide 10% of total dietary 
protein, respectively. In the second study, Tartary buckwheat protein extract, 
wheat gluten and rice protein extract were defatted previously and added to the 
diet as the only resource of dietary protein. Casein was added to diet as the control 
diet. 
The results showed clearly that Tartary buckwheat flour reduced plasma TC 
II 
and LDLC significantly compared with wheat and rice flours as well as the 
control diet. Hepatic cholesterol of Tartary buckwheat flour group was 
significantly lower than that of other groups. The fecal neutral sterol output were 
increased by the Tartary buckwheat diet significantly, this is possibly due to the 
down-regulation of intestinal Niemann-Pick CI like 1 (NPCILI) gene expression 
and more cholesterol micelles being excreted through the feces rather than 
absorbed into enterocyte. The activity of acyl-coA:cholesterol acyltransferase 2 
(ACAT2) in the intestine was also reduced (/?<0.05) in Tartary buckwheat flour • 
group. However, wheat flour and rice flour exerted little effect on the body lipid 
profile. It was concluded that Tartary buckwheat flour was a functional food 
which was more effective in reducing plasma lipids compared with wheat and rice 
flours. 
The defatted Tartary buckwheat protein extract had the best 
hypocholesterolemic effect compared with the wheat gluten and rice protein. 
Plasma TC，HDLC and non HDLC (nHDLC) as well as triglycerides (TG) were 
lowered significantly in the Tartary buckwheat protein group. The rice protein 
extract lowered the plasma TC and nHDLC levels and had no effect on the HDLC 
and TG levels. Wheat protein can lower blood TC in a slight extent at week 3 
while this effect didn't last to the end of feeding. All protein extract reduced the 
hepatic cholesterol contents significantly compared with casein diet and Tartary 
buckwheat had the greatest effect and followed by rice protein and wheat protein. 
The Tartary buckwheat protein lowered the cholesterol through lowering the ‘ 
cholesterol absorption in intestine lumen by reducing the NPCILI expression. 
The wheat protein and rice protein lowered the cholesterol synthesis in the liver 
by suppressing the 3-hydroxy-3-methylglutaryl-CoA reductase (HGMR) activity 
and increasing excretion of fecal sterol. This hypocholseterolemic effect of dietary 
grain protein may be complex results of specific amino acid composition, high 
phytosterol and flavonoid contents as well as the low protein digestibility. 
The present study demonstrated that Tartary buckwheat had the best 
III 
hypolipidemic effect compared with wheat and rice. However, wheat and rice 
flours had a limited effect on lowering blood cholesterol. This effect was 
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1.1 Cholesterol and cardiovascular disease 
Cardiovascular disease (CVD) is a class of heart and blood vessel diseases. 
Generally, it is caused by atherosclerosis, a condition of the deposition of fatty 
materials in blood vessel. CVDs are the world's biggest killers, claiming 17.1 
million lives a year. While according to World Health Organization (WHO), CVD 
can be treated and prevented. It has convincingly been shown that lowering serum 
total cholesterol (TC) and low density lipoprotein cholesterol (LDLC) levels 
retards the progression of atherosclerosis and can reduce cardiac morbidity and 
mortality (Buchwald et al, 1998; Liebson, 2004). 
Abundant data now support the conclusion that atherosclerotic disease in 
Western countries is related to a number of factors such as the level of circulating 
lipids, hypertension, smoking, and glucose intolerance (Anderson, 1991). Levels 
of cholesterol and related lipids circulating in plasma are important predictive 
tools utilized clinically to estimate risk of a cardiac event. Of these various factors, 
the plasma TC and of its main component, LDLC, are established risk factors for 
the incidence of atherosclerotic vascular complications (Tyroler, 1987). A rise in 
total cholesterol in men from 200 to 240 mg/dL is associated with a three-fold 
increase in death from cardiac diseases (Stamler et al, 2000). Epidemiological 
studies have also consistently demonstrated that plasma concentrations of high * 
density lipoprotein cholesterol (HDLC) are inversely correlated with the incidence 
of coronary artery disease (CAD) (Miller and Miller, 1975; Assmann et al, 1992). 
Nutritionally, the major concern is how dietary cholesterol and other components 
affect the circulating lipoprotein cholesterol level. 
The classical experiments conducted by Anitschkow and Chalatow (1913) 
accelerated the development of atherosclerosis in rabbits by feeding them a 
cholesterol diet. Since then, cholesterol has been recognized as an important 




1.2 Functions of cholesterol and lipoproteins 
Most cholesterol in the human body is found in cell membranes as a lipid 
bilayer modulator. One cholesterol molecule contains two functional groups, a 
polar hydroxyl group and a non-polar alkyl group, making it amphipathic (Nelson 
and Cox, 2000). Cholesterol is a critical component involved in many functions, 
such as maintaining cell membranes, and producing steroid hormones, vitamin D 
and bile acids. Cholesterol regulates membrane fluidity over the range of 
physiological temperatures and also functions in intracellular transport, cell 
signaling and nerve conduction (Leah, 2009). However, excessive amounts of 
cholesterol in cells can cause membrane disfunction, precipitate as crystals which 
will kill the cell or result in atherosclerotic damage if spread to blood (Small and 





Figure 1.1 The structure of cholesterol 
Being a lipid, cholesterol requires a transport vesicle to shield it from the 
aqueous nature of plasma in circulation. Cholesterol was transported by merging 
into micelle-like complex of various proteins and lipids through the vascular 
system. These particles, known as lipoproteins, are various in size, composition, 
function, and their contribution to vascular disease (Daniels et al, 2009). Figure 
1.2 shows the structure lipoproteins. 
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Figure 1.2 The structure of lipoprotein (internet resource 1) 
Chylomicron (CM) is a largest and least dense lipoprotein which originates 
in the intestinal mucosa. Its function is to transport- dietary triglycerides and 
cholesterol absorbed by the intestinal epithelial cells. The half life for 
chylomicron in humans is about 4.5 minutes (Zilversmit, 1979). 
LDL particle is the main transporter of cholesterol and cholesteryl esters and 
makes up more than half of the total lipoproteins in plasma. LDL particles are the 
ultimate products of the progressive triglyceride depletion of very low density 
lipoprotein (VLDL) and intermediate density lipoprotein (IDL). LDL is most 
abundant in cholesterol. The major apoprotein associated with LDL particles is 
apoB-100 in the liver and apoB-48 in intestine (Daniels et al, 2009). It is 
responsible for cholesterol transport through the circulatory system into tissues 
where cells require extracellular cholesterol. Unfortunately, LDL does not always 
reach its most appropriate destination, but rather accumulates in the infected or ‘ 
damaged intimal sub-layer of artery walls, causing atherosclerosis. That is the 
reason for calling LDLC "bad cholesterol". In this regard, the quantity of 
circulating LDLC is a well-known risk factor for heart diseases, and is the primary 
focus of most lipid lowering therapies (Mourao and Bracamonte, 1984; National 
Cholesterol Education Program, 2001). 
f 
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Table 1.1 Lipid compositions of lipoprotein classes (Internet resource 2). 
™ VLDL HDL 
Density (g/ml) < 0 . 9 4 0 . 9 4 - 1 . 0 0 6 1 . 0 0 6 - 1 . 0 6 3 1 . 0 6 3 - 1 . 2 1 0 
Diameter ( A ) 6 0 0 0 - 2 0 0 0 6 0 0 2 5 0 7 0 - 1 2 0 
Total lipids (wt%)* 9 9 91 8 0 4 4 
Triacylglycerols 85 55 10 6 
Cholesterol esters 3 18 5 0 4 0 
Cholesterol 2 7 11 7 
Phospholipids 8 2 0 2 9 4 6 
*Most of the remaining material comprises the various apoproteins. 
HDL is the smallest among the lipoproteins and is produced in the liver and 
intestine and acts like a scavenger of cholesterol. It contains a large number of 
different proteins, serves as a reversal transporter of cholesterol, and participates as 
a proteinase inhibitor in acute phase response to support the immune system against 
inflammation and parasitic diseases. HDL can bind to cholesterol in cell 
membranes by using the apo-AI protein to mediate the formation of cholesteryl 
esters. The apoD protein in HDL then activates the transfer of cholesteryl esters to 
VLDL and LDL. The principle HDL pathway, termed reverse cholesterol transport 
(RCT) plays an essential role in cholesterol removal and homeostasis. Thus, HDL is 
a well-known measurement of cardiac health due to its strong inverse relationship 
with coronary heart diseases (Wilson et al, 1988; Stamler et al, 2000) 
"4 
1.3 Cholesterol metabolism and regulation in the body 
1.3.1 Genera cholesterol metabolism 
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Figure 1.3 Main process of cholesterol metabolism in the body 
A portion of the cholesterol that is present in the diet is absorbed by the small 
intestine, incorporated into the CM particle, and delivered to the liver after partial 
degradation of the CM to its remnant (Havel, 1986; Stange et al, 1985). The arrival 
of dietary cholesterol in the liver increases the level of cholesteryl esters (CE) and 
suppresses the hepatic cholesterol synthesis from acetyl-CoA (Nervi et al, 1975). 
Almost all of the other tissues are capable of synthesizing cholesterol in various . 
rates (Spady, 1983). The cholesterol synthesized in these extrahepatic tissues must 
be transported to the liver for excretion. This process of "reverse" cholesterol 
transport presumably involves HDL (Fielding, 1987). Most cholesterol is excreted 
from the body as biliary cholesterol and bile acids and small losses of cholesterol 
through the skin and endothelial cells and the synthesis of steroid hormones, 
(Bjorkhem, 1992; Turley and Dietschy, 1988). Thus, in the steady state, the rate at 
which sterol is excreted in the feces as cholesterol .and bile acid must equal the rate 
at which cholesterol is synthesized in all of the tissues and absorbed from the diet. 
The rate of synthesis in the liver will change to accommodate any alteration in net 
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sterol balance in the animals. An increase in fecal sterol excretion, for example, will 
invariably lead to an increase in hepatic synthesis (Weis and Dietschy, 1974; 
Turley et al, 1991) while suppression of net fecal sterol loss is associated with 
inhibition of cholesterol synthesis in the liver (CarreUa and Dietschy, 1977). 
1.3.2 Cholesterol metabolism in the liver 
Liver plays a central role in maintaining net sterol balance in the body and 
rapidly responds to any disturbance of this balance by changing the rate of 
cholesterol synthesis. There are three major metabolic pathways in the liver 
(Turley and Dietschy, 1988). Firstly, LDL receptor (LDLR) takes up the LDLC 
from the circulation as an exogenous pathway. Secondly, acetate is used to 
synthesize cholesterol as an endogenous biosynthesis pathway. Thirdly, bile acid 
is made from cholesterol for biliary fluid (Russell and Setchell, 1992). 
1.3.2.1 The uptake of LDLC into the liver 
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Figure 1.4 The cellular uptake of LDL particles circulating in the blood (Brown and 
Goldstein, 2009) 
LDLC is absorbed into the liver by mediation of LDLR, which is a mosaic 
protein that mediates the endocytosis of cholesterol-rich LDL. LDLR uptakes 
LDL by recognizing the apoprotein BlOO which is embedded in the phospholipid 
outer layer of LDL particles. The receptor also recognizes the apoE protein found 
in CM remnants and VLDL remnants namely the IDL (Hobbs et al, 1992). 
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In both humans and hamsters, 60-80% of LDL particles are taken up by 
LDLR-mediated pathway (Chen et al, 1996). The number of receptors expressed 
on the cell surface is directly related to the intracellular cholesterol requirements. 
After being absorbed into the enterocyte, the LDL particles that are released from 
the receptor fuse into lysosomes, and are degraded into lipid components and 
amino acids by enzymes of the vesicle. Large portions of lipids released are CE, 
which is hydrolyzed by lysosomal acid lipase (LPA) into free cholesterol. The 
specific process of LDL absorption is explained in Figure 1.4. 
1.3.2.2 Cholesterol synthesis 
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Figure 1.5 Cholesterol formation starts with acetyl-CoA. 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR) controls the synthesis of cholesterol (Modified from Beta et al, 2007) 
,, Slightly less than half of the cholesterol in the body derives from biosynthesis « 
de 讓o. Biosynthesis in the liver accounts for approximately 10% and in the 
intestines approximately 15% of the amount produced each day. Cholesterol 
synthesis begins with the transport of acetyl-CoA from the mitochondrion to the 
cytosol. The rate limiting step is the 3-hydroxy-3-methylglutaryl-CoA reducatase 
(HMGR) catalyzed reaction (King, 2010). 
Cholesterol that has been endocytosed and converted to free form is usually 
incorporated into cell membranes depending on cell types. It has several other 
possible fates including efflux to cellular adaptors, conversion back into 
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cholesterol esters, metabolism into bile acids, or synthesis of steroids (Liscum, 
1995). 
1.3.2.3 Synthesis of bile acids 
22 24 
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Figure 1.6 Synthesis of the 2 primary bile acids, cholic acid and chenodeoxycholic acid. The 
reaction catalyzed by the 7a-hydroxylase (CYP7A1) is the rate limiting step in bile acid 
synthesis. In the intestine, primary bile acid CA and CDCA are dehydroxylated at the 
7a-position by the bacterial enzymes to produce the secondary bile acids, DCA, and LCA, 
respectively (Li and Chiang, 2009) 
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The end products of cholesterol utilization in the liver are the bile acids. 
Synthesis of bile acids is one of the predominant mechanisms for the excretion of 
excessive cholesterol. It begins with the enzymatic modulation of hepatic 
cholesterol to 7-a-hydroxycholesterol by cholesterol 7-a-hydroxylase (CYP7A1) 
(Russell and Setchell, 1992). 
1.3.2.4 RCT pathway 
RCT is a pathway by which accumulated cholesterol is transported from the 
vessel wall to the liver for excretion (Ohashi et al, 2005). Major constituents of 
RCT include acceptors such as HDL and apoA-I, and enzymes such as lecithin: 
cholesterol acyltransferase (LCAT), phospholipid transfer protein (PLTP), hepatic 
lipase (HL) and cholesterol ester transfer protein (CETP). 
A critical part of RCT is cholesterol efflux, in which accumulated cholesterol 
is removed from macrophages in the subintima in the vessel wall by ATP-binding 
membrane cassette transporter Al (ABCAl) or by other mechanisms, including 
passive diffusion, scavenger receptor B1 (SR-Bl), and collected by HDL and 
apoA-I. Esterified cholesterol in the HDL is then delivered to the liver for 
excretion. Since HDL and ApoA-I are major receptors of cholesterol in the 
cholesterol efflux, increasing HDL levels may increase cholesterol efflux and RCT, 
contributing to reduced cardiovascular disease risks (Gordon et al, 1989). 
/JJ Lipids absorption in the intestine lumen 
Early lipid digestion, from the oral cavity to the duodenum sub-layer of the 
intestine, produces crude emulsions consisting of free cholesterol, triglycerides, 
•  free fatty acids, and phospholipids. As these emulsions are delivered into the • 
intestine, they are mixed with bile salt micelles, which are synthesized and 
secreted into the intestine from the liver (Yao et al, 2002). Total concentration of 
bile salt micelles is positively correlated with cholesterol absorption (Ponz de 
Leon et al, 1981), due to catalysis of lipid emulsification into smaller droplets, 
which interact more readily with lipase enzymes (Young and Hui, 1999). 
Cholesterol absorption is achieved through passage across brush border 
membranes and into intestinal enterocytes in the jejunum. Intestinal cholesterol 
absorption efficiency in humans is highly variable, ranging from 15% to 85% in 
, healthy subjects. 
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Figure 1.7 Dietary cholesterol absorption in intestine lumen. This process is illustrated by 
the research about plant sterols, which have similar structure to cholesterol while much less 
absorption rate in intestine (Bergmann etal, 2005) 
1.3.3.1 Niemann-Pick CI like I fNPClLn 
NPCILI is a putative transporter of cholesterol, and is expressed on the 
brush border membranes of enterocytes in a general pattern that parallels that of 
maximum cholesterol absorption (David and Wang, 2007). NPCILI has been 
identified and characterized as an essential protein in the intestinal cholesterol 
absorption process. Down regulation of NPCILI can reduce the absorption of 
cholesterol and other sterols. NPCILI null mice are resistant to diet-induced 
hypercholesterolemia. Intestinal gene expression studies in NPCILI null mice 
indicated that no exogenous cholesterol was entering enterocytes lacking NPC1L1, 
which resulted in an upregulation of intestinal and hepatic LDLR and cholesterol 
biosynthetic gene expression. Intestinal expression of NPCILI is down regulated 
by diets containing high levels of cholesterol (Davis and Altmann, 2009). 
1.3.3.2 ABCG5/8 . 
Two members of the ABC transporter family, ABCG5 and ABCG8, have 
recently been implicated in mediating the secretion of sterols from the liver and 
efflux of dietary sterols from the gut (Repa et al, 2004). The expression of 
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ABCG5 and ABCG8 transporters seems to be controlled by dietary cholesterol via 
liver X receptors (LXR). Dietary cholesterol feeding leads to an increase in the 
expression of the ABCG5 and ABCG8 transporters in mice which is controlled by 
the activation of LXRs (Bergmann et al, 2005). 
1.3.3.3 Acvl-CoA:cholesterol acyltransferase (ACATl 2 
ACAT is an intracellular enzyme that catalyzes the transfer of a long chain 
fatty acyl residue from acyl-CoA to the (3-hydroxyl group of cholesterol to form a 
CE (Myant, 1990). Two ACAT genes, designated as ACAT-1 and ACAT-2, have . 
been identified in mammals (Chang et al, 2000). ACAT-1 has been found in 
macrophages of hepatic cells, adrenal glands, neurons and intestinal cells, while 
ACAT-2 is expressed in the intestinal mucosa and the liver (Burnett et al, 2005; 
Sakashita et al, 2003). ACAT2 regulates cholesterol uptake in intestine (Parini et 
al, 2004; Repa et al, 2004). ACAT-2 deficient mice had been reported to cause 
reduced intestinal cholesterol absorption (Buhman et al, 2000; Miyazaki et al, 
2003; Willner et al’ 2003; Repa et al, 2004). 
1.3.4 Cholesterol homeostasis 
Cholesterol homeostasis is maintained as a result of balance between dietary 
cholesterol absorption, endogenous cholesterol biosynthesis as well as bile acids 
synthesis and excretion. Cholesterol homeostasis is greatly modulated by proteins 
that catalyze the exchange of cholesterol and other lipids between circulating 
lipoprotein classes. And levels of intracellular cholesterol are the controlling 
element behind overall cholesterol homeostasis of every cell via their impact on 
regulating LDLR protein and de novo cholesterol synthesis. 
1.35 The regulation of the cholesterol metabolism 
1.3.5.1 The role of sterol regulatory element-binding protein 2 (SRRRP-9) 
Lipid homeostasis in animal cells is achieved by a family of transcription 
factors called SREBPs. SREBPs coordinate the synthesis of the two major 
building blocks of membranes, fatty acids and cholesterol (Brown and Goldstein, 
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Figure 1.8 The roles of SREBP-2, LDLR, HMGR, intestinal ACAT, LXR, and CYP7A1 in hepatic 
cholesterol metabolism 
Each newly translated SREBP is inserted into the ER membrane and binds to 
the SREBP cleavage activating protein (SCAP) (Osborne et al, 1988). While 
associated with SREBP, SCAP binds to another ER bound protein known as 
insulin induced gene 1 (INSIG) (Yang et al, 2002). Interaction between SCAP and 
INSIG keeps the protein complex firmly in place in the ER. Importantly, this 
interaction between SCAP and INSIG is cholesterol-sensitive, and thus, acts as the 
cholesterol sensor of this system (Brown et al, 2002). In cholesterol abundant 
conditions, membrane- spanning domains of SCAP bind to cholesterol, resulting 
in strong affinity for INSIG (Brown et al, 2002). The cholesterol-absent 
conformation of SCAP is not associated with INSIG, leaving the SREBP/SCAP 
complex free to leave the ER in caot protein II (COPII) vesicles, which then 
migrate to the Golgi (Goldstein et al, 2006). Once there, SREBP is cleaved in a 
two-step process. The nuclear form of SREBP migrates into the nucleus and 
activates genes including HMGR and LDLR, ultimately leading to increased 
cholesterol concentration in the cell (Weber et al, 2004). 
In hamster liver, when cholesterol was depleted by feeding a diet containing 
the cholesterol synthesis inhibitor lovastatin and the bile acid-binding resin 
Colestipol, the total amount of SREBP-2 increased, and efficiency of its 
proteolytic processing rose markedly. This rise in SREBP-2 was accompanied by 
ft 
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a marked increase in the amounts of target mRNAs for cholesterol-related genes, 
including HMGR and the LDLR (Brown and Goldstein, 1997). Complete 
disruption of SREBP activation in mice hepatocytes results in 75% decrease in 
sterol and fatty acid synthesis, 50% reduction in LDLR mRNA and LDL clearance, 
and a significant reduction in total plasma cholesterol (Yang et al, 2009). 
1.3.5.2 The role ofLXR 
LXR，i.e. liver X receptor, play a role in coordinating the regulation of bile 
acids and cholesterol metabolism in the liver, intestine and peripheral tissues. 
LXR is activated by naturally occurring oxysterols which are oxidized derivatives 
of cholesterol. LXR has two isoforms, LXRa and LXRp. LXRa knocked out mice 
failed to increase transcription of CYP7A1 and consequently showed a marked 
increase in hepatic cholesteryl ester concentrations. LXRp could not compensate 
for the absence of LXRa with regard to bile acid synthesis and secretion in the 
LXRa knockout mice (Peet et al, 1998). After the activation, LXRa binds to the 
LXR response element, as function as transcription factors, in the promoter region 
of the CYP7A1 (Lehmann et al, 1997). Activation of LXR is associated with an 
increase in biliary cholesterol secretion and a decrease in intestinal cholesterol 
absorption (Bergmann et al, 2005). 
1.3.5.3 Feedback regulation of cholesterol 
Whereas most of the cell cholesterol is located in the plasma membrane, the 
effectors of its abundance are regulated by a small pool of cholesterol in the ER. 
The size of the ER compartment responds rapidly and dramatically to small 
changes in plasma membrane cholesterol around the normal level. Consequently, . 
increasing plasma membrane cholesterol in vivo from just below to just above the 
basal level evoked an acute (< 2 h) and profound (^20-fold) decrease in ER 
HMGR activity in vitro (Lange et al, 2004). 
1.4 Bile acid metabolism 
1-4.1 Function of bile acids 
Bile acids are essential components in the body. Bile acids help to emulsify 




1.4.2 Bile acid synthesis 
There are two distinct pathways for bile acid synthesis: the classical (neutral) 
and the alternative (acidic) pathway. The classic or neutral pathway, common to 
all mammals, is initiated by CYP7A1 (Schwarz et al, 2001). This enzyme is 
located in the endoplasmic reticulum and catalyzes the rate-limiting step in the 
neutral pathway (Russell, 2003). The mitochondrial sterol 27-hydroxylase is 
suggested to be the limiting enzyme in alternative bile acid synthesis (Daniel and 
Zempleni, 2003). CYP7A1 is responsible for the 7a hydroxylation of cholesterol 
into 7a-hydroxycholesterol, the first and rate-limiting step in bile acid synthesis 
(Norlin and Wikvall, 2007). 
Dietary cholesterol increases mRNA and activity of CYP7A1 as a 
compensatory response to maintain cholesterol homeostasis in rats (Pandak et al, 
1991). Changing the activity of CYP7A1 would cause the change of the blood 
cholesterol (Hubacek and Bobkova, 2006). 
Intestinal bacterial microflora is responsible for the cholesterol metabolism. 
The probable mechanism involves an indirect pathway with 4-cholesten-3-one as 
the intermediate. This compound is formed by the oxidation of the 3 
beta-hydroxyl group to a ketone and isomerization of the 5-6 double bonds to the 
4-5 position. Coprostanone is formed by the reduction of the 4-5 double bonds. 
And, coprostanol is formed by the reduction of the 3-keto to a hydroxy 1 group" 
(Lichtenstein, 1990). The concentration of coprostanol is much higher than 
coprostanone (Eyssen and Parmentier, 1974). 
It was suggested that the composition of the intestinal microflora was 
dependent on diet. Variation of dietary intakes influenced intestinal secretions and 
the substrates available for the bacterial metabolism (Aries et al., 1969). 
1.4.3 Enterohepatic circulation of bile 
Bile acids are secreted into bile after synthesis and amidation. The bile acids 
are efficiently reabsorbed from the intestine, return to the liver and are resecreted 
into bile. This cyclical movement of bile acids from the liver into the intestine, 
back to the liver and back into the intestine is termed the enterohepatic circulation 
(Hofmann, 1984). In humans, the bile acid pool size is around 2.5-3g and it 
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completes an enterohepatic cycle about 6-10 times per day. The daily loss of bile 
acid in feces is about 0.2-0.6g and they are compensated by de novo synthesis by 
the liver to maintain the bile acid pool constant. The enterohepatic circulation of 
bile acids serves as an important physiological route not only for recycling of bile 
acids and absorption of nutrients but also for regulation of whole-body lipid 
metabolism. This process also acts as messengers that carry signals from intestine 
to liver (Chiang, 2009). 
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Figure 1.9 Enterohepatic circulation of bile acids (Chiang, 2009) 
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1.5 Effect of Dietary composition on blood cholesterol 
人 5.1 Dietary cholesterol 
The concentration of LDLC usually increases as the level of dietary 
cholesterol is increased (Mattson et al, 1972). On average, clinical feeding studies 
have shown that an increased dietary cholesterol by lOOmg increases circulating 
cholesterol by 2.2-2.5mg/dl, with a 1.9mg/dl increase in LDLC, and a 0.4 mg/dl 
increase in HDLC. However, when relatively large amounts of cholesterol reach 
the liver, de novo synthesis and LDL uptake are rapidly down-regulated (Kruit et 
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al, 2006). . 
As the amount of cholesterol in the diet is increased, sterol synthesis in the 
liver is essentially fully suppressed. In general, cholesteryl esters in the 
hepatocyte is proportional to the amount of cholesterol absorbed, and LDLR 
activity is reduced dependent on the amount of sterol absorbed (Spady and 
Dietschy, 1988). If such cholesterol feeding is continued, the circulating LDLC 
concentration increases more slowly until a new steady-state level is achieved, the 
latter is also dependent upon the amount of cholesterol absorbed through the 
intestine (Spady and Dietschy, 1988). For example, in the young male hamsters, 
the plasma LDLC level will increase from 25 mg/dl to new steady-state values of 
40, 55, and 90 mg/dl when 0.06, 0.12, and 0.24% cholesterol is added to the diet, 
respectively. Similarly, the human infant increases its LDLC level from 25 to 90 
mg/dl as the content of sterol in its milk is progressively raised from 0 to 15 mg/dl 
(Cruz et al, 1991); the human adult increases its LDLC concentration from about 
50 to 120 mg/dl as the daily intake of cholesterol is raised from 20 to 160 mg 
(Connor et al, 1978). It is noted that these increments in LDLC concentration in 
the hamster require the daily intake of amount of cholesterol of 160 mg/kg that is 
4 times higher than the daily synthesis rate in this species ( � 4 0 mg/kg); similar 
increases in LDLC can be induced in the human infant and adult at much lower 
intakes of sterol ( � 2 4 and 2 mg/day per kg, respectively) relative to whole animal 
synthesis rates ( � 2 5 and 9 mg/day per kg, respectively) (Grobe, 1982; Turley and 
Dietschy, 1988). 
Thus, the primary effect of cholesterol feeding is to expand the storage pool 
of cholesteryl esters in the hepatocyte and reduce the level of hepatic LDLR 
activity. These changes, in turn, reduce the percentage of LDLC cleared by the 
receptor-dependent process in the whole animal. 
1.5.2 Dietary protein 
1.5.2.1 Research history of dietary protein on the cholesterol 
Newburgh and Squier (1920) observed atherosclerotic lesions in rabbits on a 
high casein diet. Years later, Meeker and Kesten (1940) showed clearly that 
rabbits fed a high protein cholesterol-free diet, with casein as the source of protein, 
became hypercholesterolemic and developed atherosclerosis, whereas these 
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effects were not observed when soybean flour replaced the casein in the diet 
(Carroll, 1977). This was the first time to demonstrate that dietary protein asserted 
an effect on the serum cholesterol. Howard et al (1965) reported that 
hypercholesterolemia and atherosclerosis could be reduced in rabbits by replacing 
the casein in the diet by whole soy flour or by hexane-extracted soy bean meal. 
A series of feeding trials were thereafter designed to identify the dietary 
component responsible for the hypercholesterolemic response in rabbits fed 
cholesterol-free, semipurified diets (Hamilton and Carroll, 1974; Carroll and 
Hamilton, 1975; Hamilton and Carroll, 1976). In these studies, the different • 
components of the semipurified diet were varied systematically, and it was found 
that the hypercholesterolemia was related to the use of casein as the source of 
protein. Other proteins derived from animal sources, such as egg protein, 
lactalbumin, fish protein, or beef protein, also gave a hypercholesterolemic 
response, but when the casein was replaced on an isonitrogenous basis by protein 
preparations from plant sources, the plasma cholesterol remained low and was 
generally in the range seen in rabbits fed commercial diet. 
1.5.2.2 Dietary casein 
An increased in plasma LDL cholesterol level induced by casein was 
observed in different species (Chao et al, 1986). One important mechanism that 
contributes to the hyperlipidemic action of casein is that it can increase absorption 
and reabsorption of cholesterol and bile acids in the intestine (Damasceno et al, 
2001). The increase in the influx of cholesterol and bile acids from the intestine to 
the liver promotes an increase in the hepatic amount of both components. The 
liver responds by an inhibition on cholesterol biosynthetic and catabolic pathways ‘ 
and a reduction of the number of apo-B/E receptors (Vahouny et al, 1985). In fact, 
it has been demonstrated that casein-fed rabbits and rats showed decreased 
HMGR activity, as well as down regulation of CYP7A1 and of apo-B/E receptor 
leading to decreased cholesterol catabolism and delayed removal of lipoproteins 
from blood plasma (Scarabottolo et al, 1986). Moreover, casein increases the 
production of cholesteryl ester-rich VLDL in the liver (Chao et al, 1986) and, by 
reducing the activity of LDLR (Scarabottolo et al, 1986) stimulates further 
conversion of VLDL to LDL. Casein also reduces the transfer of apo-E and C 
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from VLDL to HDL, resulting in accumulation of these proteins on VLDL and 
IDL particles and, finally, LDL cholesterol (Roberts et al, 1981). 
1.5.2.3 Sov protein 
The hypocholesterolaemic effect of soya products is well documented (Huff 
and Carroll, 1980), although there is some dispute over whether it is the amino 
acids or non-protein components, e.g. isoflavoness that are responsible for the 
cholesterol-lowering effect of soya. In contrast to the casein, soy protein promotes 
a reduction of intestinal (re)absorption of bile acids and cholesterol in animals 
(Carroll, 1977), leading to increased activity of cholesterol-7a-hydroxylase (Potter, 
1995) and apo-B/E receptor (Samman et al, 1990)，which has an important 
hypocholesterolemic effect. Soy protein isolate stimulates the transfer of these 
apolipoproteins from VLDL to HDL. 
1.5.2.4 Buckwheat protein 
The hypocholesterolemic effect of buckwheat protein has been demonstrated 
in several animal models such as rats and hamsters (Kayashita et al, 1996; 
Tomotake et al, 2000; Tomotake et al, 2007). When added to the rats' diet, 
buckwheat protein extract could lower the plasma TC by 13.4% compared with 
the casein group when the diet was free of cholesterol (Kayashita et al, 1996). In 
the presence of dietary cholesterol, the consumption of buckwheat protein extract 
could maintain plasma TC at the normal level (Kayashita et al, 1995) or decreased 
by 32% in rats (Tomotake et al, 2007). Fecal neutral cholesterol excretion was 
also enhanced significantly by the dietary buckwheat protein compared with the 
soy protein and casein (Kayashita et al, 1997). 
1.5.2.5 Mechanism of dietary protein on the cholesterol 
The specific mechanism of hypolipidemia of plant protein was remained not 
known. The possible explanations were due to a low lysine: arginine ratio 
(Gudbrandsen et al, 2005) and a low digestibility (Tomatake et al, 2006) which 
could cause the increasing fecal sterol excretion. 
1.5.3 Dietary fiber 
The influence of certain dietary fiber on lipid metabolism and atherosclerosis 
in animals and in man is recognized at VO^*^  last century (Kritchevsky 1978; Huang 
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et al, 1978). Dietary fiber includes two major classes, water soluble and water 
insoluble. Insoluble dietary fiber such as cellulose and pectin has a limited effect 
in lowering cholesterol by increasing the volume of stools (Mueller et al, 1984). 
Meta-analysis concluded that soluble fiber 2-lOg/d was associated with small but 
significant decreases in total cholesterol and LDL cholesterol (Brown et al, 1999), 
at the same time with a slightly decrease at HDL-cholesterol. The water-soluble 
NSP were presumed to act by forming viscous solutions in the gut that small 
intestinal reabsorption of bile acid lowered, leading to increased fecal steroids 
excretion and a fall in plasma cholesterol concentration. Currently, the possible 
mechanisms of soluble dietary fiber have three hypotheses: 1) binding with the 
bile acid in liver: Some soluble fibers bind bile acids or cholesterol during the 
intraluminal formation of micelles (Anderson and Tietyen-clark, 1986). The 
resulting reduction in the cholesterol content of liver cells led to an up-regulation 
of the LDLRs and thus increased clearance of LDLC. In cholesterol-fed rats, 
excretion of fecal neutral sterols but not acidic sterols was significantly higher as 
a result of feeding soluble dietary fiber compared with cellulose (Arjmadi et al, 
1992); 2) inhibiting of hepatic fatty acid and cholesterol synthesis: this 
mechanism was conducted by products of fermentation (production of short-chain 
fatty acids such as acetate, butyrate, propionate) (Nishina and Greedland, 1990). 
1.5.4 Other functional components in the diet 
1.5.4.1 Phvtosterols 
Phytosterols are also known as plant sterols. P-sitosterol, campesterol and 
stigmasterol are the most common and abundant phytosterols in nature. They have 
a similar construction to cholesterol, which contain one or two methyl or ethyl 邋 
groups in the molecula's side chain. 
The blood cholesterol reducing effect of phytosterols was described 50 years 
ago (Pollack, 1953). It was not until the 1990s that significant advances were 
made to find their use as functional ingredient. Many trials have confirmed the 
ability of phytosterols to reduce LDLC, without significantly altering 
HDL-cholesterol or triglycerides in general (Temme et al, 2002; Vanstone et al, 
2002; Amundsen et al, 2002). A meta-analysis of these trials concluded that daily 
intake of 2 g of plant sterols or stanols similarly reduces LDLC by 10% (Katan et 
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al, 2003). The cholesterol lowering action is most marked with the 4-desmethyl 
sterols (P-sitosterol, stigmasterol) or stanols (sitostanol), and it has been 
demonstrated that the 4,4-dimethyl sterols have little or no activity in humans. 
The specific effects of the 4-monomethy sterols and sterol glycosides are not 
known. A22-sterols (stigmasterol, brassicasterol) strongly inhibited the cholesterol 
synthesis through the competitive inhibition of sterol A24-reductase (Fernandez et 
al，2002). Ostlund (2002) reviewed one well-controlled study, which used purified 
phytosterols and was performed in rats, found no differences in effects on 
cholesterol absorption between esterified and nonesterified A5-sterols or between 
purified sitosterol oleate, stigmasterol oleate, and campesterol oleate. 
Basic mechanism of action of these compounds, which was commonly 
accepted, is that, in appropriate conditions, they can become efficiently 
incorporated into the micells in the intestimal lumen, displace the cholesterol, and 
lead to its precipitation with other, non-solubilised phytosterols to decreased 
cholesterol absorption by 50% (Quiliez et al, 2003; Kamal-Eldin, 2009). And 
other evidence proved that plant sterols can inhibit cholesterol absorption without 
being present in the intestine with dietary cholesterol at the same time (Mel'nikov 
et al, 2004). The molecular actions of plant sterols including effects on intestinal 
and liver cholesterol transporters and gene expression, for example, LXR and 
NPC 1 LI, provoked the wide interesting (Calpe-Berdiel et al, 2009; Altmann et al, 
2004). A greater plant sterol concentration in the enterocyte determines a 
decreased expression of NPCILI and an over-expression of the ABCAl 
transporter and helps to decrease the absorption of cholesterol (Yu et al, 2002; 
Field et al’ 2004). Besides, Cholesterol and plant sterols down-regulate SREBP-2 
leading to inhibition of the sterol regulatory element (SRE) and the intestinal 
activity of HMGR thus inhibition the cholesterol biosynthesis (Calpe-Berdiel et al, 
2009). However, Plosch et al (2006) used C57BL/6J mice and ABCG knocked 
mice test the effect of oral intake sterols and stanols (0.5g/100g) on lipid 
metabolism. Feeding plant sterols and stanols did not alter intestinal expression of 
ABCG5, ABCG8 or other LXR target genes nor of NPCILI. 
Human body cannot synthesize phytosterols, thus, these components are 
obtained only from the diet, phytosterols are found in all foods of plant origin, 
usually accurs in vegetable oils, muts, cereals, beans, and seeds, their dietary 
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intake varies from 150-350 mg/day, or even higher in vegetarians in Western diets. 
For incorporation into foods, phytosterols are often esterified with fatty acids to 
improve their fat solubility (Kerckhoffs et al, 2002). 
1.5.4.2 Dietary flavonoids 
Flavonoids are polyphenolic compounds that are ubiquitous in nature and are 
categorized, according to chemical structure, into flavonols, flavones, flavanones, 
isoflavones, catechins, anthocyanidins and chalcones. Over 4,000 flavonoids have 
been identified, many of which occur in fruits, vegetables and beverages (tea, 
coffee, beer, wine and fruit drinks). The flavonoids have aroused considerable 
interest recently because of their potential beneficial effects on human health-they 
have been reported to have antiviral, anti-allergic, antiplatelet, anti-inflammatory, 
antitumor and antioxidant activities. They are also reported to possess the ability 
to lower cholesterol. , 
Rats were given diet containing 0.1% rutin and 0.1% cholesterol, respectively. 
5 weeks later, the rutin group observed significantly decrease in plasma lipids 
level except the HDL-C level, and the hepatic cholesterol was significantly lower 
by 32%. The hepatic ACAT activity was significantly lowered in rutin group, 
however, there was no effect on the HMGR activity. The reduced ACAT activity 
in these groups may have led to less cholesteryl ester being available for VLDL 
packing, thereby resulting in a reduction of VLDL secretion from the liver (Park 
et al, 2002). Dietary quercetin had been shown to reduce serum total cholesterol 
in animals fed a cholesterol-enriched diet. Igarashi and Ohmura (1995) reported 
that rats fed a cholesterol-enriched diet had lower serum total cholesterol when 
diets were supplemented with quercetin at 0.2% of diet. In rabbits fed a high-fat ‘ 
diet, quercetin given orally (50|ag/kg/d) was effective in reducing serum 
triglycerides and cholesterol levels. However, sudieds from other animal models 
are controversial. Yugarani and others (1992), in a rat model of diet-induced 
atherosclerosis, have found a reduction of HDL cholesterol concentration in rats 
supplemented with quercetin (lOOmg/rat/day), but significant elevation of LDL 
cholesterol at 10 week of the strudy with no effect on total cholesterol levels. 
Hayek and others (1997) reported that consumption of quercetin (50|ig/mouse/d) 
had no effect on plasma LDL or HDL cholesterol levels in atherosclerotic 
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apolipoprote in apoE deficient mice. . 
1.6 Chemical composition of Tartary buckwheat 
There are two species of buckwheat namely common buckwheat 
(Fagopyrum esculentum) and Tartary buckwheat {Fagopyrum tataricum) with the 
latter being grown in more harsh climatic conditions (Bonafaccia, 2003; Lin, 
1992). Common buckwheat is widely used for noodle and bread. However, the 
use of Tartary buckwheat into the food is much limited in the past due to its bitter 
and odd flavor. Generally, two kinds of buckwheat have the similar composition. 
From the nutritional point of view, Tartary buckwheat grain contains proteins with 
a high biological value and a balanced amino acid composition (Javornik, 1981; 
Bonafaccia et al, 2003), In addition, Tartary buckwheat contains higher crude 
fiber，greater amount of vitamin Bl, B2, and B6 (Bonafaccia et al, 2003); and 
more rutin than common buckwheat (Kitabayashi, 1995). Thus it is potential to be 
developed as an important functional food material. 
Table 1.2 Compare the chemical composition of Tartary buckwheat with common cereal flour 
(% dry matter basis) (Bonafaccia and Fabjan, 2003) 
Crops Protein Ash Lipids Dietary fiber 
Soluble Insoluble Total 
10.3 1.8 2.5 0.5 5.3 6.5 
buckwheat 
Common n.O 2.6 3.4 1.2 5.3 6.5 
buckwheat 
Wheat 11.5 1.7 1.0 1.0 1.5 2.4 
Rice 6.8 0.5 0.6 0.1 1.8 1.9 
Oats 12.6 1.8 7.1 3.3 4.9 10.2 
Rye V U 1_5 1.8 3.6 ^ 13.6 
1.6.1 Buckwheat protein 
Buckwheat flours contain 10%-12.5% of proteins, which is less only than oat 
flour, but significantly higher than those in rice, wheat and other grains (Chineses 
Preventive Medicinal Academy, 1991). The amino acids in buckwheat protein are 
well balanced and are rich, compared with other crops, in lysine, which is 
generally the first limiting amino acid in other plant proteins, and arginine, thus 
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can complement well with other vegetable proteins (Li and Zhang 2001). The 
Lys/Arg and Met/Gly ratios in buckwheat proteins are lower than those in most 
other plant proteins, which mean that buckwheat proteins should have a strong 
cholesterol-lowering effect, according to Huff and Carroll (1980), Sugiyama 
(1985), and Carroll et a/(1995). 
1.6.2 Dietary fiber 
Fiber analysis shows that Tartary and common buckwheat contain similar 
amount at levels of 6% (dry-weight basis) in the flours and common buckwheat 
grain contains a higher ratio of soluble dietary fiber than Tartary buckwheat 
(12.99 vs. 8.27) (Bonafaccia et al, 2003). Relative little is known about the 
composition and properties of soluble dietary fiber in buckwheat. Asano et al 
(1970) isolated water soluble non-starch polysaccharides from buckwheat and 
reported that they consisted of xylose, mannose, galactose, and glucuronic acid. 
1.6.3 Phytosterols 
The phytosterols found in buckwheat seeds, although at a low level, showed 
positive lowering effects on blood cholesterol level. Phytosterol exist commonly 
through the whole buckwheat, but the distribution and content of phytosterols can 
vary from different tissues. The most abundant sterol in embryo and endosperm 
tissues is P-sterol, which accounts for 70% of the total sterols. Other sterols are 
campesterol and traces of stigmasterol. The content of sterols in buckwheat are 
P-sterol of 77.5士3.0 mg/lOOg, campesterol of 9.3士0.6 mg/lOOg and trace 
stigmasterol according to the method of Pironen et al (2002), and P-sterol of 86 
mg/lOOg, campesterol of 11 mg/lOOg, and stigmasterol trace with the method of " « 
Normen et al (2007). These results are well consistent with the results reported by 
Han et al (2007) who showed the average content of sterols in buckwheat was 
P-sterol 74.52 mg/lOOg, campesterol 8.57 mg/lOOg and stigmasterol 0.95 
mg/lOOg. 
1-6.4 Flavonoids---rutin andquercetin 
Buckwheat contains many flavonoid compounds, known for their 
effectiveness in reducing the blood cholesterol, keeping capillaries and arteries 
strong and flexible, and assisting in prevention of high blood pressure (Santos et 
f 
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al, 1999). Six flavonoids have been identified in buckwheat grain. In buckwheat 
hulls all the six flavonoids (rutin, quercetin, orientin, vitexin, isovitexin and 
isoorientin) were found. In buckwheat seeds, only rutin and isovitexin were found 
and mainly as rutin (Dietrych-Szostak and Oleszek, 1999; Kreft et al, 1999). 
Rutin is the unique component in the buckwheat, especially Tartary buckwheat 
contain high level rutin of 2%, which is nearly 200 folds compared with those of 
common buckwheat which is the main resource of its bitter taste (Morishita et al, 
2007). Tartary buckwheat seeds contained traces of quercitrin and quercetin, 




Effect of Tartary Buckwheat Flour 
on 
Blood Cholesterol Level in Male Hamsters 
2.1 Introduction 
Tartary buckwheat (Fagopyrum tataricum Gaertn.) is a cultivated, 
self-pollinating species of buckwheat that accumulates large amounts of 
functional components in its seeds. It is grown and used in the mountainous 
regions of southwest China, northern India, Bhutan, and Nepal (Fabjan et al, 
2003). It tastes much bitter than common buckwheat because of more contents of 
flavonoids such as rutin (Bonafaccia, Marocchini and Kreft, 2003). 
Tartary buckwheat diet is consumed in China with a long history. In Shanxi 
province, Tartary buckwheat diet is used to improve the health of patients with 
diabetes and cardiovascular disease as well as in the treatment of wounds and 
ulcers because of antibacterial properties (He, 1998; Wieslander et al, 2000). It 
had been reported that Tartary buckwheat could help to lower serum lipid level in 
the diabetes mellitus patients when an equal amount of composite Tartary 
buckwheat flour substituted 30% of ordinary cereal in the subjects' diabetic diet 
with the treatment and drugs unchanged during the experiment (Lu et al, 1992). In 
another study, hyperlipidemia patients got lower serum TG and TC after eating ‘ 
Tartary buckwheat flour without medication (Lin et al, 1998). A higher individual 
buckwheat consumption in this population was related to lower serum TC and 
LDLC，and higher ratio of HDLC to TC (He et al, 1995). 
There were few studies using Tartary buckwheat flour as animal diet 
component, as far as known. Son (2008) studied the effect of common buckwheat 
on the body lipid level using high male SD rats compared with adlay, barley and 
white rice. Buckwheat flour could significantly lower the TC by 16%, LDLC by 
350/0 and TG level by 21%, respectively, while increased the HDLC level by 20%, 
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compared with white rice at the present of 1% dietary cholesterol. In another 
research, female Wister rats were used and similar results were obtained in TC, 
LDLC and TG, however, the HDLC was significantly lowered when compared 
with the conventional diet group (Pre'stamo et al, 2003). 
Japanese studies have indicated that some of the beneficial effects of 
buckwheat might be related to its low digestibility of the buckwheat proteins and 
special composition of amino acid (Kayashita, 1997; Ikeda, 1998). However, the 




The present study was the first time to evaluate and compare the 
hypocholesterolemia ability of Tartary buckwheat with another two kind of 
common cereal foodstuffs, wheat and rice flours and with a casein diet as control. 
To be able to evaluate the functional differences of these grains, the diet 
compositions in this study used the same level of dietary protein content provided 
by the flour. Furthermore, natural flours were used rather than any extracts to 
study the effect of the natural flours that people really eat in their daily diet. This 
investigation was mainly to focus on the cholesterol-lowering action mechanism 
of Tartary buckwheat flour at the molecular level. 
2.3 Materials and methods 
2.3.1 Hamsters 
Thirty-six (110-115 g, age = 2 months) male Syrian golden hamsters 
{Mesocricetus auratus), were obtained from the Laboratory Animal Services 
Centre，The Chinese University of Hong Kong. They were randomly divided into 
four groups (n=9/group) and housed in wire-bottom cages at 23�C with a 12-h 
light-dark cycle in the animal room. The protocol was reviewed and approved by 
the Experimental Animal Ethics Committee, The Chineses University of Hong 
Kong. 
Hamsters were given frozen diets daily, and uneaten portion was discarded. 
The hamsters were allowed to access the food and water ad libitum. Food intake 
was measured daily and body weight was recorded weekly. The total fecal output 
“ of each hamster was manually separated from other bedding materials and was * 
pooled in each week throughout the experiment. Blood was collected from the 
retro-orbital sinus into a heparinized capillary tube at the end of week 0, 3 and 6 
after the overnight food deprivation. The blood was centrifuged at 1500g for 10 
minutes and the plasma was collected and stored at -20 °C until analysis. 
At the end of 7出 week, all hamsters were killed after the overnight fasting. 
The blood was collected via the abdominal aorta. After clothing, the blood was 
centrifuged at 1500g for 10 min, and plasma was collected. The liver, heart, 
kidney and adipose tissue (perirenal and epididymal pads) were removed, 
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washed with ice-cold saline, weighed and stored at -80°C until analysis. The 
first 5cm of duodenum was discarded, and the following 30 cm of the small 
intestine was kept with the first 15cm for mRNA analysis and the second 15cm 
for measuring the ACAT enzyme activity. All tissue samples were flash frozen 
in liquid nitrogen and stored at -80°C until analysis. 
2.3.2 Diets 
Diet ingredients were purchased from Harlan Teklad (Madison, WI, USA) 
except for lard, corn starch, plain wheat flour, and rice flour, which were obtained 
from the local market, and Tartary buckwheat flour were purchased from Shanxi 
Province in main land China. DL-methionine and cholesterol were purchased 
from Sigma Chemical (St. Louis, MO, USA). All diets contained 0.1% cholesterol. 
The experimental diets contained 10% of total protein provided by Tartary 
buckwheat flour, wheat flour and rice flour, respectively, whereas the control diet 
had its protein coming from casein. 
The control diet was prepared by mixing the following ingredients in 
proportion (g/kg diet): cornstarch, 510; casein, 240; lard, 50; sucrose, 118; mineral 
mix AIN-76, 40; vitamin mix AIN-76A, 20; DL-methionine, 1; cholesterol, 1. The 
other three experimental diets were prepared by substituting the casein with 
different flours to provide 10% total dietary protein. All flours' protein contents 
were calculated as approximately 10%. Due to the flours also contain starch, so 
the starch contents of diets were compensated by adjusting the addition of corn 
starch. The powdered diets were then mixed with gelatin solution (20g/L) (Table 
2.1). Once the gelatin had set, the food was cut into 15g cubed portions and stored 
in a freezer at -20°C. 
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Table 2.1 Composition of the control group (Control), buckwheat flour group 
(Buckwheat), wheat flour group (Wheat) and rice flour (Rice) group (g/kg). 
Control Buckwheat Wheat Rice 
Casein 240 216 216 216 
Tartary buckwheat flour 240 
Wheat flour 240 
Rice flour 240 
Corn starch 510 294 294 294 
Lard 50 50 50 50 
Sucrose 118 118 118 118 
Mineral mix 40 40 40 40 
Vitamin mix 20 20 20 20 
DL- mathionine 1 1 1 1 




The chemical compositions of Tartary buckwheat flour, wheat and rice flour 
were measured according the protocol reported previously. Generally, crude 
protein were measured according the Kjedahl method (979.09; AO AC, 1990)， 
using a nitrogen to protein conversion factor of 5.75. Crude fat were measured 
by Soxhlet Extraction method. Dietary fiber was determined using an enzymatic 
kit of Megazym K-TDFR (Wicklow, Ireland). Carbohydrate content was 
calculated by subtracting protein, ash, water, lipids and total dietary fiber from 
total weight. Fatty acids were identified by comparison with a chromatographic 
profile of standards using GC. 
Flavonoid contents such as rutin were determined by HPLC. Rutin was 
extracted by shaking with 80% methanol for 12 hours at 37°C. The ratio of the 
flour to solvent was 0.2: 30. The mixture was centrifuged and supernatant was 
filtered through 0.45 urn PVDF membrane and then subjected to HPLC (Shimazu, 
Tokyo, Japan) with a Hypersil ODS C18 5n (25mm X 4.6mm, 5|im, Alltech, 
Deerfield, Illinois, USA). The mobile phase was solvent A: 1% acetic acid; 
solvent B: acetonitrile and kept B at 20% for 30 min to separate rutin. The flow 
rate was 0.8ml/min. Rutin content was detected at 360 nm with a UV detector. 
Phytosterols were extracted and determined by GC according to the method 
described by Toivo (2000, 2001) with a slight modification. Briefly, 0.5g flour 
sample was subjected to acidic hydrolysis in 6 N HCl solution and alkaline 
hydrolysis in 1 N NaOH in 90% ethanol consequently. The unsaponifiables were 
extracted with cyclohexane. Supernatant was dried under nitrogen gas. 
Phytosterols extracted were converted to their trimethylsilyl (TMS)-ether 
derivatives by a commercial TMS-reagent (dry pyridine-hexamethyldisilazane-
trichlorosilane，9: 3: 1, v/v/v, Sil-A regent，Sigma). After 1 hour at 60�C, the 
mixture was evaporated under nitrogen gas. The TMS-ether derivative was 
dissolved in 500 \xL of hexane for GC analysis. 
2.3.3 Determination of plasma lipoproteins 
Plasma TC and TG were measured using their respective commercial 
enzymatic kits from Infinity (Waltham, MA, USA) and Stanbio Laboratories 
(Boerne, TX, USA), respectively. The concentration of HDLC was measured after 
precipitation of LDL and VLDL with phosphotungstic acid and magnesium 
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chloride, using a commercial kit (Stanbio Laboratories, oerne, TX, USA). nHDLC 
was calculated as the difference between TC and HDLC. 
2.3.4 Determination of cholesterol concentration in organs 
Total lipids were extracted from lOOg of organ sample with addition of 1.5 
mg of 5-a cholestane (Sigma, St Louis, MO, USA) as an internal standard using 
15 mL chloroform-methanol (2:1, v/v) and 3 mL saline. The chloroform-methanol 
phase was removed and dried down under a gentle stream of nitrogen gas. The 
lipid extracts were saponified in 6 ml of IN NaOH in 90% ethanol at 90�C for 1 
hour. Water was added and the cholesterol was extracted by cyclohexane. The 
cyclohexane phase was evaporated to dryness under nitrogen gas. Cholesterol was 
converted to their trimethylsilyl (TMS)-ether derivatives by 300|liL of 
TMS-reagent. After 1 hour at 60°C, the mixture was evaporated under nitrogen 
gas. The TMS-ether derivative was dissolved in 600 |iL of hexane. After 
centrifugation, the hexane phase was transferred into a GC vial for gas-liquid 
chromatograph (GLC) analysis. The analysis of cholesterol TMS-ether derivative 
was performed in a fused silica capillary column (SAC TM-5, 30m x 0.25 mm, 
i.d.; Supelco，Inc., Bellefonte, PA, USA) using a Shimadzu GC-14 B GLC 
equipped with a flame ionization detector (Shimadzu, Kyoto, Japan). The column 
temperature was set at 285°C and maintained for 20 minutes. Helium was used as 
a carrier gas at a head pressure of 22 psi. A typical GLC chromatogram of liver 
cholesterol is shown in Figure 2.1. 
2.3.5 Determination of fecal neutral and acidic sterols output 
Neutral and acidic sterols in the feces were determined by a method ‘ 
described by Czubayko et al (1991) with slight modification. The collected feces 
were dried in a lyophilizer, weighed and ground into powder. 5-a cholestane (0.5 
mg) in 1 mL of chloroform was added as an internal standard for neutral sterols in 
a methylation tube, and was dried down under nitrogen gas. Then about 300 mg of 
fecal sample was weighed into the very tube together with 0.3 mg hyodeoxycholic 
acid (Sigma) in IN NaOH in 90% ethanol. The samples were then hydrolyzed in 8 
mL IN NaOH in 90% ethanol at 90°C for 1 hour. The total neutral sterols were 
extracted using 8 ml of cyclohexane and converted to their corresponding 
TMS-ether derivatives for GLC analysis. The remaining aqueous phase was saved 
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for the acidic sterol analysis. • 
The TMS-ether derivatives of neutral sterols were dissolved in 400|LIL of 
hexane and transferred into a GC vial and subject to GC analysis with the same 
GC column which organ cholesterol analysis used. The column temperature was 
maintained at 285°C for 30 minutes. A typical chromatogram is shown in Figure 
2.2. 
The remaining lower aqueous phrase was added into 1 mL of 1 ON NaOH and 
heated at 120°C for 3 hours. After a cooling down to the room temperature, 5ml of 
distilled water and 3 mL of 25% HCl were added followed by extraction with 7 ml 
I 
of diethyl ether twice. The diethyl ether layers were then pooled followed by 
adding 2 ml of methanol, 2 mL of dimethoxypropane and 40 |JL of concentrated 
HCl (37%). After standing overnight at room temperature, the solvents were dried 
down and the acidic sterols were similarly converted to their TMS-ether 
derivatives at 60°C for GLC analysis. 
The TMS-ether derivatives were dissolved in 300 of hexane, transferred 
into a GC vial and ubject to GC analysis with the same GC column which organ 
cholesterol analysis used. The column temperature was programmed from 230�C 
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Figure 2.1 Gas liquid chromatogram profile of cholesterol in the liver. Peak identification of 
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Figure 2.2 Gas liquid chromatogram of fecal neutral sterol analysis. Identification of peaks: 1， 
5a-cholestane (internal standard); 2, coprostanol; 3, coprostanone; 4, cholesterol; 5， 
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Figure 2.3 Gas liquid chromatogram of fecal acidic sterol analysis. Identification of peaks: 1， 
lithocholic acid; 2，deoxycholic acid; 3, chenodeoxycholic acid + cholic acid; 4’ 




2.3.6 Western blotting of liver SREBP-2, LDLR, HMGR, LXR and CYP7A1 
proteins 
Total hepatic proteins were extracted according to the method described by 
Vaziri & Liang (1996) with some modifications. In brief, frozen liver was 
homogenized in a buffer containing 20mM Tris-HCl (pH 7.5), 2 mM MgC12, 
0.2M sucrose and Complete® protease inhibitor cocktail (Roche, Mannheim, 
Germany). The extract was centrifuged at 13,000 g for 10 minutes at 4 °C and the 
supernatant was collected as the ‘total proteins'. A portion of the total proteins 
was then centrifuged at 35,000 g for one hour at 4 The supernatant was 
removed and the pellet, 'membrane proteins', was resuspended in the buffer 
described above. Protein concentration of the two fractions was determined using 
a protein assay kit (Bio-Rad, Hercules, CA, USA). 
For the measurement of LDLR, CYP7A1, LXR, SREBP-2 and HMGR, 
100|Lig of the membrane protein was size-fractionated on a 7 % SDS-PAGE gel at 
130V for one hour. The proteins were then transferred to Immobilon-P PVDF 
membrane (Millipore Corporation, USA). Blocking solution (5% nonfat milk in 
1 XTBST) was used for the one hour incubation and then overnight in the same 
solutions containing 1: 600 anti-LDL receptor antibody (Calbiochem, USA), 
1:200 anti-CYP7Al (Santa Cruz Biotechnology, California, USA), 1:400 
anti-LXR antibody (Santa Cruz Biotechnology), 1:400 anti-SREBP-2 antibody 
(Santa Cruz Biotechnology) or 1:500 anti-HMGR (Upstate USA Inc., Lake Placid, 
NY, USA) as primary antibody whichever appropriate. 
The membrane was then washed three times for 15 minutes in 1 x TBST and 
incubated for one hour at 4�C in diluted (1:3000) horseradish peroxidase-linked 
rabbit anti-goat IgG (Zymed Laboratories Inc., San Francisco, CA, USA) or 
donkey anti-rabbit IgG (Santa Cruz Biotechnology). The washes were repeated 
before the membranes were developed with enhanced chemiluminescence (ECL) 
agent (Santa Cruz Biotechnology) and subjected to autoradiography for one to 
five minutes on Super i^ medical X-ray film (Fuji, Tokyo, Japan). Densitometry 
was quantified using the computer software Photoshop® (Adobe Systems Inc, CA, 
USA). 
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2.3.7 Real-time PCR analysis of mRNA or liver SREBP-2, LDLR, HMGR, 
and CYP7A1 and small intestine NPCILI, ABCG5, ABCG8, ACAT2, and 
MTP 
Total mRNA levels in the liver SREBP-2, LDLR, HMGR, LXR, and 
CYP7A1 were quantified as previously described (Jiao et al, 2010). In brief, total 
mRNA was extracted using Tizol Reagent (Invitrogen, Carslbad, CA, USA) and 
converted to cDNA using a High Capacity cDNA Reverse Transcription kit 
(Applied Biosystems, Foster City, CA). Reverse transcription was carried out in a 
thermocycler (GeneAmp PCR system 9700, Applied Biosystems), with the 
program set as initiation for 10 min at 25°C, followed by incubation at 50°C for 
90 min and at 85 °C for additional 5 min. The cDNA synthesized was stored at 
-20 °C. Total small intestinal mRNA was similarly extracted and converted to 
cDNA. , 
Real-time PCR analysis was carried out on a Fast Real-time PCR 
System7500 (Applied Biosystems, Foster City, CA) for both the hepatic and small 
intestinal genes. Primers and TaqMan probes were used for real-time PCR for the 
liver GAPDH, CYP7A1, HMGR, LDLR, SREBP-2, and in hamsters, whereas for 
the small intestinal NPCILI, ABCG5, ABCG8, ACAT2, MTP, and cyclophilin, 
SYBR green was used as a fluorophore. The reaction mixture was subjected to 
thermal cycling under the following conditions: heating to 95 V in 20 s, followed 
by 40 cycles at 95 °C for 3 s and 60 V for 30 s. Data were analyzed using the 
Sequence Detection Software version 1.3.1.21 (Applied Biosystems). Gene 
expression was calculated according to the comparative threshold cycle (CT) 
method (Applied Biosystems). The expressions of target genes were normalized 
with that of GAPDH and cyclophilin for liver and intestine, respectively. 
2.3.8 Intestinal ACAT2 activity measurement 
Firstly，the intestinal mucosa protein was extracted. The mucosa sample was 
thawed and then homogenized in a homogenizer (Wheaton, San Diego, CA, USA) 
on ice. The mixture was centrifuged at 2000 g for 15 minutes at 4�C. The 
supernatant containing the cytosol was transferred to a new vial and thepellet was 
discarded. The supernatant was centrifuged again. Derived supernatant was 
f 
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transferred to a polycarbonate centrifuge tube (Beckman) and centrifuged at 
38,000 g for 60 minutes at 4�C. The supernatant was discarded and 1 mL 
homogenizing buffer (0.05 M Tris, 1 M KCl, with Complete® protease inhibitor 
cocktail (Roche)) was used to resuspend the pellet as the microsome. CHAPS 
(Sigma) was added with constant mixing to final concentration of 2% (w/v) and 
stored at -80 °C until analysis. Aliquot of the microsome was taken for 
determination of protein concentration using a commercial protein assay kit 
(Bio-rad). 
Intestinal ACAT activity was measured as described previously by Cadigan 
& Chang (1988); Chang et al (2000); Zhang (2003). Microsome was adjusted 
with a solubilization buffer to a protein concentration of 1 mg/150 |iL. Cholesterol 
in 45% (w/v) 2-hydroxypropyl p-cyclodextrin aqueous solution (400 nmol) was 
added into 1 mg of microsome and incubated on ice for 30 minutes and then in a 
37 °C water bath for 5 minutes to equalize temperature. The reaction was initiated 
by adding an assay reagent of 0.517 nmol of [^ "^ C] oleoyl-Coenzyme A (0.03|iCi) 
(Perkin-Elmer, Waltham, MA, USA), 7.483 nmol of non-radioactive 
oleoyl-Coenzyme A (Sigma) and 10 nmol of fatty acid-free bovine serum albumin 
(Sigma) followed by incubation in a 37 °C water bath for 20 minutes. The reaction 
was stopped by adding 4.8 mL chloroform: methanol mixture (2:1, v/v) and 1 mL 
saline and then chilling on ice. After the addition of 10 \ig [^H] cholesterol oleate 
(0.002 jiCi) (as internal standard for loss correction), the mixture was centrifuged 
at 800 g for 10 minutes at 4 °C and the lower organic layer was collected and 
evaporated under a gentle nitrogen stream until dryness. Cholesteryl oleate (lOjig) 
in 50 |iL of chloroform was added and vortex thoroughly. The resuspension was 
spotted on a thin-layer chromatography (TLC) plate (Merck, NJ，USA) and then 
developed in hexane: ethyl acetate: acetic acid (80:20: 1, v/v) for 45 minutes. The 
plate was dried and stained in iodine vapor. The band corresponding to cholesterol 
oleate was cut off according to a cholesteryl oleate standard developed in parallel 
and transferred to a scintillation vial. Containing 10 mL of OptiPhase HiSafe 2 
scintillation fluid (Perkin-Elmer) and the mixture was incubated with agitation 
overnight. Radioactivity was measured in an LS 6500 scintillation counter 




Results were presented as means 士 standard deviation (SD). Where 
applicable, one-way analysis of variance (ANOVA) and post hoc LSD test were 
used to statistically evaluate significant differences among the control, buckwheat 
flour, wheat flour and rice flour groups using SPSS (version 16.0, Statistical 
Package for the Social Sciences software, SPSS, Chicago, USA), a, b, c in the 





2.4.1 Nutritional composition of different flours 
Composition in Tartary buckwheat flour, wheat flour and rice flour used in 
experimental was analyzed (Table 2.2). Tartary buckwheat flour had the highest 
level of protein, fat and dietary fiber, especially for total dietary fiber, which was 
almost 5-folds that of wheat and rice flour. The fatty acid composition of different 
flours was also measured (Table 2.3). Tartary buckwheat flour had a far less 
saturated fatty acid than wheat and rice flour while more monounsaturated fatty 
acid at nearly 45% of total lipids. Besides, Tartary buckwheat flour contained 
74.42 mg/lOOg phytosterols, which was 2.2-folds and 5.1-folds of wheat flour and 
rice flour, respectively (Table 2.4). The content of rutin in Tartary buckwheat was 
1.143g/100g dry weight, which were 127-folds of rice and wheat flour. 
The lipid contents of the experimental flours were 2.57% in Tartary 
buckwheat flour, 1.35% in wheat flour and 0.4% in rice flour (Table 2.2). The 
energy per 100 g was 320, 344, 337 kcal, respectively. Accordingly, the energy 
contents were calculated as 3,450 kcal/kg of the casein diet, 3,218 kcal/kg of the 
Tartary buckwheat flour diet, 3,275 kcal/kg of the wheat flour diet, and 3,258 
kcal/kg of the rice flour diet, respectively. So there were no differences on dietary 





















































































































































































































































































































Table 2.3 Fatty acid composition (% total) of lipids derived from Tartary 
buckwheat (Buckwheat), wheat (Wheat) and rice flour (Rice) used in the 
experiment (%) 
Buckwheat Wheat Rice 
10:0 0.03 0.18 0.22 
12:0 0.03 0.08 0.10 
14:0 0.13 0.25 2.72 
16:0 13.38 41.64 43.81 
18:0 2.22 2.09 3.07 
20:0 1.23 0.23 0.36 
22:0 1.27 0.47 0.36 
saturated 44.94 50.62 一 
16:1 (n-9) 0.12 0.21 0.07 
16:1 (n-7) 0.19 0.17 0.14 
18:1 (n-7) 40.34 12.67 16.41 
18:1 (n-7) 1.68 0.14 0.61 
20:1 (n-9) 2.10 0.55 0.53 
20:1 (n-7) 0.26 0.14 0.17 
22:1 (n-9) 0.66 0.43 0.19 
monounsaturated 45.34 14.30 18.12 
18:2 (n-6) 34.82 38.91 30.22 
18:3 (n-3) 1.41 1.62 1.04 
20:3 (n-9) 0.05 0.03 0 
20:4 (n-6) 0.01 0.02 0 
22:5 (n-6) 0.00 0.07 0 
22:6 (n-3) 0.09 0.10 0 
polyunsaturated 36.37 40.75 31.26 
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Table 2.4 Phytosterol and rutin contents in Tartary buckwheat flour, wheat flour 
and rice flours (mg/lOOg). 
Buckwheat Wheat Rice 
P-Sitosterol 60.74土5.38 19.30土0.39 9.50士 0.21 
Campesterol 6.77±0.65 4.86土0.30 2.65土 0.24 
Stigmasterol 1.57 士0.22 0.59土 0_ 18 1.45 士 0.17 
P-Sitostanol ND 6.18 土0.10 0.37士 0.07 
Campestanol ND 1.60 士 0.20 ND 
Avesterol 5.34±0.47 1.03±0.01 0.54 士 0.10 
Total phytosterols 74.42士5.79 33.56土0.16 14.51 土0.65 
腕 in " 4 3 . 0 士67.8 9.0士 0.6 8.7 士 0.3 




2.4.2 Growth, food intake and relative organ weights 
No significant differences were observed in body weight and food intake 
among the groups (Table 2.5). After normalizing to body weight, the relative 
weights of liver, kidney, heart and adipose tissue are shown in Table 2.6. There 
were no significant differences in organ weights among the four groups. 
2.4.3 Effect of different flour diets on plasma lipid profile 
The increased plasma TC and nHDLC induced by dietary cholesterol were 
significantly lowered by Tartary buckwheat flour (/7<0.05). The wheat flour diet 
had no effect on TC and nHDLC levels but it increased the HDLC content 
significantly compared with the control diet. The rice flour lower the TC, nHDLC 
as well as HDLC insignificantly. Ratio of nHDLC/HDLC was significantly 
lowered in all the three experimental groups compared with the control group, 
Tartary buckwheat flour elevated the ratio of HDLC/TC which were not observed 
in other three groups. There was no significant difference on the TG levels among 
the four groups (Table 2.7). 
2.4.4 Effect of different flour diets on organ cholesterol of hamsters 
The hepatic cholesterol in Tartary buckwheat flour group was significantly 
lower (/?<0.01) than the other groups (Table 2.8). There was also an increasing 
cholesterol level in the heart of the wheat flour group. 
2.4.5 Cholesterol balance and excretion of fecal neutral and acidic sterols 
The apparent cholesterol absorption was calculated by the equation 
[(cholesterol intake - excretion of neutral and acidic sterols) / cholesterol intake]. 
Tartary buckwheat group observed a significant increase of neutral sterols 
output and an increasing trend of acidic sterols and thereby resulted in a 
significant lower net cholesterol retain (Table 2.9). Fecal neutral sterols were 
mainly as form of coprostanol and dihydrocholesterol in Tartary buckwheat flour 
group (Table 2.10). Fecal sterol excretions were enhanced in wheat flour group 
and resulted in insignificant lower net cholesterol retention due to significant 
lowered cholesterol intake. Rice flour had no effect on sterol output as well as 
cholesterol net retain. 
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Table 2.5 Body weight gain and food intake of hamsters fed the control diet and 
the experimental diets supplementation of Tartary buckwheat flour (Buckwheat), 
wheat flour (Wheat), rice flour (Rice) which all contain 0.1% cholesterol (g). 
Control Buckwheat Wheat Rice 
Initial body weight 113.89 ±6.51 114.38 土 12.94 119.44 土 7.68 120.00 士 11.99 
Final body weight 120.25 士 10.31 121.88 士 12.36 122.78 士 4.41 128.78 士 14.13 
Body wt. gain 7.13 土 7.59 7.44 ±6.58 3.33 土 8.29 8.78 土 14.04 
Food intake 11-58 ±0.97 11.57 土 1.19 10.08 土 0.97 12.32 ±1.64 




Table 2.6 Relative weights of liver, heart, kidney, epididymal fat, perirenal fat and 
testis of hamsters fed the control diet and the experimental diets supplementation 
of Tartary buckwheat flour (Buckwheat), wheat flour (Wheat), rice flour (Rice) 
which all contain 0.1% cholesterol (g/lOOg body weight). 
Control Buckwheat Wheat Rice 
Liver 3.80 士0.29 3.77士0.20 3.61 土0.46 3.84士 0.21 
Heart 0.35 士0.02 0.33土0.02 0.33士0.02 0.34士 0.03 
Kidney 0.77±0.08 0.78士0.06 0.76士0.05 0.77士 0.05 
Testis 3.31 士0.17 3.22土0.34 3.38土0.25 3.06士 0.31 
Epididymal fat 1.36土0.23 1.41 土0.29 1.26士0.46 1.40士0.23 
Perirenal fat 0.67土0.19 0.70士0.17 0.73士0.36 0.78±0.20 
Values were expressed as mean 士 SD (n=9). 
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Table 2.7 Levels of serum TC, HDL, non-HDL, the ratio of non-HDL to HDL 
and TG of hamsters fed the control diet and the experimental diets 
supplementation of Tartary buckwheat flour (Buckwheat), wheat flour (Wheat), 
rice flour (Rice) which all contain 0.1% cholesterol at week 0 and week 6. 
VVeek Control Buckwheat Wheat Rice 
T C (mg/dL) 0 1 1 4 . 3 4 土 9 . 0 1 1 1 3 . 7 6 士 7 . 9 9 1 1 3 . 8 4 ± 8 . 7 9 1 1 2 . 2 3 士 9 . 7 1 
6 2 8 2 . 4 1 ± 2 3 . 6 2 a 2 3 9 . 2 9 ± 1 8 . 3 1 “ 2 8 1 . 6 3 ± 1 4 . 0 0 ^ 2 6 5 . 9 8士 3 3 . 8 4 a 
TG (mg/dL) 0 1 1 5 . 1 5 士 9 . 5 8 1 0 6 . 4 6 士 1 1 . 4 4 1 0 6 . 8 4 士 1 6 . 4 4 1 2 1 . 4 9 土 2 3 . 5 3 . 
6 1 6 0 . 2 5 士 4 5 . 6 6 1 3 3 . 1 7 土 4 1 . 1 0 1 4 6 . 4 1 土 2 3 . 5 4 1 3 6 . 3 7 士34 .08 
H D L C 0 5 3 . 6 2 ± 4 . 8 1 5 2 . 3 2 ± 2 . 6 1 5 4 . 8 2 ± 2 . 9 6 5 2 . 0 2 ± 2 . 1 4 
(itig/dL) 6 1 2 2 . 8 4 土 6 . 1 6 b 1 2 0 . 4 4 士 9 . 2 4 b 1 3 0 . 6 0 士 6 . 0 5 a 1 2 3 . 4 0 士 1 3 . 4 0 “ 
n H D L C 0 6 0 . 7 2 ± 5 . 6 2 6 0 . 5 8 ± 5 . 9 9 6 0 . 6 5 ± 1 2 . 1 2 6 2 . 9 6 ± 1 6 . 9 5 
(mg/dL) 6 159 .57士 20.17 a 118.85士 1 4 . 9 3 b 1 5 1 . 0 3 ± 1 2 . 0 0 ^ 1 4 2 . 5 8 土 2 2 . 8 7 a 
n H D L C / 0 1 . 1 4 ± 0 . 1 1 1 . 1 6 ± 0 . 0 9 1.11 ± 0 . 2 2 丨 .21 士 0 . 3 2 
H D L C 6 1.：30 士 0 . 1 5 a 0 . 9 9 士 O . M b 1 . 1 6 士 O . l O b 1 . 1 5 ± 0 1 3 b 
H D L C 0 0 . 4 7 士 0 . 0 2 0 . 4 6 土 0 . 0 2 0 . 4 8 士 0 . 0 5 0 . 4 5 土 0 . 0 2 
6 0 . 4 4 士 0 . 0 3 b 0 . 5 0 士 0 . 0 3 a 0 . 4 6 土 0 . 0 2 b 0 . 4 7 土 0 . 0 3 “ 




Table 2.8 The organ cholesterol content in hamsters fed the control and three 
experimental diets supplemented with Tartary buckwheat flour (Buckwheat), 
wheat flour (Wheat), rice flour (Rice) (mg/g). 
Control Buckwheat Wheat Rice 
Liver 63.35士9.47 ' 43.27士3.60 b 57.11 土6.28 a 52.34士4.64 a 
Kidney 4.76 士0.17 4.56士0.18 4.62士0.47 4.24士 0.69 
Heart 1.64±0.09'' 1.64 士 0.11 b 1.74±0.07' 1.59 士 0 . 10 ' 




Table 2.9 Cholesterol balance in hamsters fed the control and three experimental 
diets supplemented with Tartary buckwheat, wheat and rice flours per day in week 
6 (mg per hamster per day). 
Control Buckwheat Wheat Rice 
Neutral sterol 1.07 土 0.20 b 2.57 士 0.67 a 1.45 士 0.31 匕 0.82 土 0.14 b 
Acidic sterol 1.09 士 0.35 1.61 士 0.59 1.12 土 0.63 1.03 士 0.52 
Cholesterol intake 12.26 士 0.51 a 11.28 土 0.64 b 10.18 土 0 . 8 0 � 13.17 土 0.29 a 
Cholesterol 
retained 10.09 士 0.30 a 7.09 士 1.44 b 7.36 ±1.08'' 11.32 土 0.72 a . 
Cholesterol 
retained/intake 82.43 土 3.69 a 62.56 土 9.62 b 72.47 士 10 2r’b 85 91 士 3 68 a 
(%) 





Table 2.10 Fecal neutral and acidic sterol composition in hamsters fed the control 
and three experimental diets supplemented with Tartary buckwheat, wheat and 
rice flours in week 6 (mg per hamster per day). 
Diet group Control Buckwheat Wheat Rice 
Neutral sterols 
Coprostanol 0.52土0.25 ‘ 0.88士0.34 ‘ 0.62士0.24 ‘ 0.27土0.09 ‘‘ 
Coprostanone 0.05土0.01 ‘‘ 0.08士0.02 ‘ 0.07士0.02 ‘ 0.04士0.02 ^ 
C h o l e s t e r o l 0.24 士0.18 0.32土0.07 0.20士0.10 0.20士 0.07 
Dihydrocholesterol 0.16±0.02^ 0.34土0.08 “ 0.23士0.04 b 0.15士0.04 b 
Campesterol 0.06士0.02 e 0.71 士0.23 a 0.25±0.08 ^ 0.11 士0.03 e 
Stigmasterol 0.04士0.01 b 0.07士O.Or 0.05士0.02 a，b 0.03士0.01 b 
Sitosterol 0.01 士0.01 b 0.17±0.10' 0.03士0.03 b 0.02±0.01^ 
Total neutral j, ^ h h 
1.07 士 0.20b 2.57 土 0.67a 1.45 士 0.31 b 0.82 士 0.14b 
sterol 
Acidic sterols 
Lithocholic acid 0,64士0.26 0.80士0.35 0.53士0.20 0.58士0.27 
Deoxycholic acid 0.10±0.08^ 0.23土0.03 a 0.11 ±0.03*^ 0.14士0.10 a，b 
Chenodeoxycholic 
. . ： . 0.29±0.10 0.52士0.23 0.34士0.32 0.25士0.13 
acid + cholic acid 
Ursocholic acid 0.05士0.07 0.07士0.04 0.09土0.08 0.06士0.04 
Total acidic sterol 1.09士0.35 1.61 士0.59 1.12士0.64 1.03±0.52 
Values were expressed as mean 士 SD (n=5). Means at the same row differ significantly at 
p<0.05 (a, b, c) 
"50 
2.4.6 Effect of different flour diets on hepatic SREBP-2, HMGR, LDLR and 
CYP7A1 immunoreactive mass 
The Western Blot analysis and real time PGR showed that hepatic LDLR, 
CY7A1, SREBP-2 and HMGR immunoreactive mass did not differ among the 
four groups (Figure 2.4 and 2.5). There was only a slight decreasing trend in 
relative HMGR and LDLR gene expressions while an increasing trend in relative 
CYP7A1 gene expression of Tartary buckwheat group. Wheat diet group had the 
same trend as Tartary buckwheat diet while with a lighter extend. As for the rice 
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Figure 2.4 Effect of buckwheat flour, wheat and rice flours on the relative 
immunoreactive mass of hepatic sterol regulatory element-bingding protein-2 
(SREBP-2), liver X receptor (LXR), 3-hydroxy-3-methylglutatry-CoA reductase 
(HMGR), LDL receptor (LDLR), and cholesterol-7a-hydroxylase (CYP7A1) as 
determined by Western blot analysis. Data are normalized with p-actin so that 
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Figure 2.5 The mRNA of hepatic sterol regulatory element-binding protein-2 (SREBP-2), 
3-hydroxy-3-methylglutary-CoA reductase (HMGR), LDL receptor (LDLR) and 
cholestero丨-7a-hydroxylase (CYP7A1) in hamsters fed "the control and three experimental 
diets. Bars with different letters (a-b) were significantly different atp < 0.05. 
f 
53 
2.4.7 Effect of different flour diets on intestinal ABCG5, ABCG8, NPCILI, 
MTP, and ACAT2 immunoreactive mass 
No significant difference was observed in the intestinal ABCG5&8 and MTP 
relative gene expressions among the groups. However, RT-PCR analysis 
demonstrated that dietary Tartary buckwheat flour intake was associated with the 
significant decreased expression of mRNANPCILI and ACAT2 (Figure 2.6). 
2.4.8 Effect of different diet group on intestinal ACAT activity 
The intestinal ACAT showed a lower enzyme activity in the Tartary 
buckwheat group compared with the control group. In contrast, wheat and rice 
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Figure 2.6 The relative mRNA of intestinal Niemann-Pick CI like 1 (NPCILI) , ATP-binding 
cassette (ABC) transporters sub-family G member 5 and .8 (ABCG5/8), acyl-CoA: cholesterol 
acyltransferase 2 (ACAT2) and microsomal triglyceride transfer protein (MTP) in hamsters 
fed the control and three experimental diets. Bars with different letters (a-b) were significantly 
different a t /7< 0.05. 
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Figure 2.7 Effect of buckwheat flour, wheat flour and rice flour on the intestinal acyl 
coenzyme A: cholesterol acyltransferase (ACAT) activity in hamsters fed a 0.1 % cholesterol 
diet. Values are expressed as means 土 SD (n=9) Bars with different letters (a-b) are 




The present study was the first time to evaluate the effects of Tartary 
buckwheat, plain wheat flour and rice flour on the lipoprotein profile. The 
hamsters were fed diets containing these three flour equivalent to 10% of total 
dietary protein. 
The three flours demonstrated the varying effects on plasma lipids in hamster. 
Tartary buckwheat flour could significantly reduce plasma TC and nHDLC levels 
as well as hepatic TC level compared with the control diet (Table 2.7 and 2.8). 
Tartary buckwheat flour used in this experiment reduced plasma TC level by 10% 
compared with the rice flour diet. This was consistent with the other report of Son 
et al (2008) who added the common buckwheat flour into the rats' diet at nearly 
50% level and led a decreased TC by 16% compared with white rice flour diet. 
They also observed elevated plasma HDLC level while we didn't. Fecal 
excretion of neutral and acidic sterols is a part of cholesterol homeostasis. 
Reduction of plasma TC was accompanied by an increase in fecal neutral sterol 
output mainly as the form of coprostanol and dihydrocholesterol in Tartary 
buckwheat group (Table 2.9 and 2.10). These were consistent with another 
report in which common buckwheat was used (Tomotake et al., 2006). In the 
present experiment, wheat flour didn't exert an effect on neither fecal neutral 
sterol nor acidic sterol output; this was opposite to the research carried out by 
Illman et al (1993) who found white wheat flour could lower the plasma TC and 
increase both neutral sterol and acidic sterol output compared with the whole 
wheat and wheat bran. As though there'was no difference on the plasma TC, TG 
,‘ and nHDLC of wheat flour group compared with the control group, there was a ‘ 
significant higher HDLC level than that of control group which resulted in a lower 
ratio ofnHDLC/HDLC (Table 2.7). The ratio ofnHDLC/HDLC was identified as 
a main indicator associated to the risk of atherosclerosis. Several large 
epidemiological and clinical studies have found the LDLC/HDLC ratio to be an 
excellent predictor of CHD risk and an excellent monitor for the effectiveness of 
lipid-lowering therapies (Manninen et al, 1992; Cullen et al, 1997; Kannel 2005; 
Fernandez and webb, 2008). Rice flour only lowered ratio of nHDLC/HDLC 
group compared with the control group (Table 2.7). Kempner (1946) showed the 
, cases that rice diet could lower the serum TC of patients with hypertensive 
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vascular disease. Substitution of sucrose with clear flour caused a significant 
decrease in hypercholesterolemic rats. However, this effect tended to be less 
pronounced with time prolong. 
In the present experiment, a significantly suppress in ACAT2 gene 
expression and lowered ACAT activity were observed in Tartary buckwheat group 
compared with the other three groups. Beside, real time PGR analysis 
demonstrated that mRNA NPCILI of Tartary buckwheat group was 
down-regulated compared with that in the control group. Regulation of cholesterol 
absorption plays an important role in maintaining the whole body cholesterol 
homeostasis (Chen et al, 2008). Dietary cholesterol absorption in the intestine was 
governed by two types of transporters, NPCILI and the ABCG5/8. NPCILI 
transports cholesterol from the lumen into enterocytes. Intestinal ACAT2 then 
converts cholesterol to cholesteryl ester and subsequently the absorbed cholesterol 
is transferred into blood through the lymphatic system as the form of CM (Jiao et 
al, 2010). Those unesterified cholesterol are shuttled back to the lumen by 
ABCG5/8. Inhibition on the ACAT2 activity has been found to be effective in 
preventing hepatic cholesterol accumulation and hypercholesterolemia in animal 
models (Homan and Krause, 1997) and down-regulating NPCILI through 
SREBP-2 binding to the two sterol regulatory elements in the NPCILI promoter 
(Davis and Altmann, 2009). A subtle up-regulated CYP7A1 gene expression in the 
liver might have contributed this phenomenon and reduced hepatic cholesterol at 
some extent. Since no significant change was observed in the hepatic LDLR 
expression, the hypolipidemic effect of Tartary buckwheat flour was probably 
associated with inhibition on ACAT activity. 
Numerous studies suggest that phytosterols have beneficial effect on 
lowering blood lipids level (Pollack, 1953; Temme et al, 2002; Vanstone et al, 
2002; Amundsen, 2002; Katan et al, 2003). Plant sterols are naturally occurring 
sterols and structurally related to cholesterol. It's known that phytosterols can 
incorporate into the micelles competing with the cholesterol in the intestinal 
lumen to reduce the gut absorption of cholesterol (Quiliez, Garcia-Lorda and 
Salas-Solvado, 2003; Kamal, Moazzami, 2009). It had confirmed the ability of 
phytosterols to reduce LDLC without significantly altering HDLC or TG in 
general in hyperlipidemic subjects (Temme et al, 2002; Vanstone et al, 2002; 
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Amundsen, 2002). A meta-analysis of these trials concluded that daily intake of 2 
g of plant sterols or stands similarly reduces LDLC by 10% (Katan et al, 2003). 
However, in a previous research, buckwheat lipids which contained phytosterol at 
2.26mg/100g were extracted and added to the diet (Kayashita et al, 1997), finding 
there was no influence of the buckwheat lipids on plasma and liver cholesterol in 
rats compared with corn oil. It was also reported that as little as 150 mg com oil 
phytosterols could significantly reduce cholesterol absorption (Ostlund et al’ 
2002)，showing that natural existing phytosterol can be bioactive at relatively 
small amounts (Ostlund, 2004). In the present study, Tartary buckwheat flour 
contained total phytosterols of 74.42 mg/lOOg which was twice that of wheat flour 
and 5-folds that of rice flour (Table 2.4). Phytosterols accounted for 2.18土0.11, 
14.44±0.23, 8.03士0.09 and 5.30±0.01 mg/lOOg for casein, Tartary buckwheat 
flour，wheat flour and rice flour diets, respectively, which was higher than that of 
previous study. Recently, new insights into the molecular actions of phytosterols 
on intestinal and liver cholesterol transporters and gene expression were found 
(Kamal-Eldin and Moazami, 2009). These included the up regulation of the 
ABC transporters by interacting with LXR (Field et al, 2004) and down 
regulationof the SREBP2, leading to inhibition of the sterol regulatory element 
and activity of HMGR (Calpe-Berdiel et a!, 2009). In-vitro studies have shown 
that the intestinal esterification is less efficient for phytosterol than for cholesterol 
thus phytosterol may in a competitive way suppress ACAT activity and 
consequently reduce intestinal cholesterol uptake (Trautwein et al, 2003). This 
finding indicated that phytosterols maybe contributed partially to the 
cholesterol-lowering activity of Tartary buckwheat flour. 
«» < 
Buckwheat protein contains a balance amino acid composition and is 
characterized by a high lysine, glycine and arginine content (Bonafaccia, 
Marocchini and Kreft, 2003). Buckwheat protein has been demonstrated to be 
hypolipidemiable in rats and hamsters (Kayashita et al, 1995; Kayashita et al, 
1996; Tomotake et al, 2000; Tomotake，et al, 2001). However, most studies were 
carried out with common buckwheat. Tartary buckwheat was reported to contain 
similar amino acid composition to the common buckwheat. Tomotake et al (2007) 
reported that Tartary buckwheat protein extract had some inhibitory effect against 
hypercholeseterolemia in cholesterol-fed rats. Kritchevsky et al (1982) found that 
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higher arginine/lysine ratio of soy protein isolate .may contribute to it 
hypolipidemic effect. In few studies, supplementation of lysine to a soy 
protein-based diet indeed had a hypercholesterolaemic effect and supplementation 
of arginine to a casein-based diet had a hypocholesterolaemic effect (Kritchevsky 
et al, 1987; Rajamohan et al, 1990). It was also suggested that glycine 
supplementation to a casein-based diet lowered the serum cholesterol 
concentration in rats (Sugiyama et al’ 1986). However, the results of the studies 
were variable and the mechanism underlying was not clear. The 
hypocholesterolemic effect of buckwheat protein may also partially due to the low 
digestibility of buckwheat protein compared with casein according to Kayashita et 
al (1997) and Tomotake et al (2007). 
There was a higher content of flavonoids, a kind of plant phytochemicals that 
cannot be synthesized by humans, in Tartary buckwheat flour. Flavonoids such as 
rutin were famous for its activity on lowering blood glucose. It was found to 
lower the blood cholesterol too. Rats given 0.1% dietary rutin can inhibit plasma 
TC and nHDLC elevation caused by dietary cholesterol and hepatic ACAT2 
activity was significantly lowered by dietary rutin (Park et al, 2001). With a 
higher content of total flavonoids at 154 mg/g dry matter, geminated buckwheat 
could increase serum HDLC and HDLC/TC ratio (Choi et al, 2007). The effective 
dietary rutin intake was 20-60mg per day (0.1% of dry diet weight) to achieve a 
lipid-lowering effect (Choi et al, 2007, Park et al, 2002). Rutin is a unique 
flavonoid in Tartary buckwheat and qualitatively accounts for 2% by weight, 
which is nearly 200-folds of that in common buckwheat (Morishita, 2007). In 
present study, tartary buckwheat flour contained rutin of l.lg/lOOg, which was 
approximately 130-folds that of wheat and rice flour. The average flavonoids 
intake was 31.8 mg per day (0.2% of dry diet weight, see Table 2.4), 0.26 mg and 
0.24mg, respectively, for Tartary buckwheat diet, wheat diet and rice diet, it 
seemed that the level of rutin intake in the present study may exert cholesterol 
lowering effect. In addition, Kuwabara et al (2007) found rutin-rich Tartary 
buckwheat sprout powder lowered plasma cholesterol by increasing fecal sterol 
output and up-regulating of the hepatic CYP7A1 gene expression, which was 




Dietary Tartary buckwheat flour could lower the plasma TC and nHDLC 
levels as well as hepatic cholesterol levels compared with casein, wheat flour and 
rice flour in male hamsters. Supplementation of Tartary buckwheat flour in diet 
led to greater neutral sterol excretion compared with supplementation of the wheat 
and rice flours. Plasma TG, HDLC and fecal acidic sterol were, however, not 
affected by supplementation of Tartary buckwheat flour. The cholesterol-lowering 
activity of Tartary buckwheat flour was probably associated with its inhibition on 
cholesterol absorption, most likely mediated by down-regulation of the gene 





Effect of Defatted Tartary Buckwheat Protein 
Extract on 
Blood Cholesterol Level in Male Hamsters 
3.1 Introduction 
Tartary buckwheat seed contains approximately 10-12.5% protein, which is 
higher than that of other cereals except for oat. The buckwheat protein is more 
balance and rich for its high content of lysine, which is generally the first limiting 
amino acid in plant protein (Li and Zhang, 2001). 
Dietary buckwheat protein could lower the blood cholesterol level in rats and 
hamsters (Kayashita et al, 1996; Tomotake et al, 2000; Tomotake et al, 2007). 
When added to the rats' diet without cholesterol, buckwheat protein extract could 
lower the plasma TC by 13.4% compared with the casein (Kayashita et al, 1996). 
In the presence of dietary cholesterol, buckwheat protein extract could maintain 
plasma TC at the normal level in rats (Kayashita et al, 1995) or decrease it by 32% 
(Tomotake et al, 2007). Fecal neutral cholesterol excretion was also enhanced 
significantly by the dietary buckwheat protein both in rats and hamsters compared 
with soy protein isolate (Kayashita et al, 1997，Tomotake et al, 2000). It was 
reported buckwheat protein can inhibit fat deposition into the fat tissue in rats 
(Kayashita et al, 1996). 
Most previous studies focused mainly on common buckwheat. Recently, 
interest in Tartary buckwheat is growing. However, there is very limited 





The present experiment was carried out to investigate the hypocholesterolemic 
activity of defatted Tartary buckwheat protein (TBP) compared with casein, wheat 
protein extract (WP) and rice protein extract (RP) and explore the underlying 
molecular mechanism. 
3.3 Materials and methods 
3.3.1 Hamsters 
Forty (110-115 g, 2 months old) male Syrian golden hamsters {Mesocricetus 
auratusl were obtained from the Laboratory Animal Services Centre, The 
Chinese University of Hong Kong. They were randomly divided into four groups 
(n=10/group), and were maintained similarly in an animal room as described in 
2.3.1, Chapter 2. 
3.3.2 Diets 
WP as wheat protein and RP as rice protein extract were commercially 
purchased from Pufa Technology Co., Ltd (Shenzhen, China) and Jindege sugar 
Industry Co., Ltd (Wuhan, China), respectively. TBP was produced from Tartary 
buckwheat flour according to the method described by Tomotake et al (2007). 
Briefly, Tartary buckwheat flour was suspended in distilled water and the pH was 
adjusted to 8.0. The suspension was mixed well and precipitated. The pH of the « 
supernatant was adjusted to 4.5 to isoelectrically precipitate the protein. The 
obtained precipitate was redispersed in the deionized water. The dispersion was 
adjusted to pH 7.0 and freeze dried. The crude TBP was then defatted by 
soaking with the ethyl ether at 37°C for 12 hours and filtered with Buchner ftinnel 
and dried in an dry oven at temperature not higher than 50�C. Both WP and RP 
were similarly defatted. 
The control diet was prepared by mixing the following ingredients in 
‘ proportion (g/kg diet): cornstarch, 510; casein, 240; lard, 50; sucrose, 118; mineral 
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mix AIN-76, 40; vitamin mix AIN-76A, 20; DL-methionine, 1; cholesterol, 1. The 
other three experimental diets were similarly prepared by substituting the casein 
with three defatted protein extracts to provide 20% dietary protein. The starch 
contents of diets were compensated by adjusting the addition of corn starch (Table 
3.1). As shown in Chapter 2, the powdered diets were then mixed with gelatin 
solution (20g/L), cut into 15g cubed portions and stored in a freezer at -20°C. 
Composition of defatted TBP, WP, and RP was measured as described in 
Chapter 2. Generally, the crude protein was quantified using the Kjedahl method 
(979.09，AO AC, 1990) and a factor of 6.25 was applied to convert the nitrogen 
value to protein. Crude fat was measured by Soxhlet Extraction method. Dietary 
fiber was determined using an enzyme kit supplied by Megazym K-TDFR 
(Wicklow, Ireland.). Phytosterol were measured following the method described 
in 2.3.1, Chapter 2. 
The amino acid composition of three protein extracts was determined 
following a method described by the Standardization Administration of the 
People's Republic of China (GB/T 5009.12-2003). Briefly, protein samples were 
hydrolyzed in 6N HCl solution under vacuum at 110 °C for 22 h. The amino acid 




Table 3.1 The composition (g/kg) of four diets with addition of casein, Tartary 
buckwheat protein extract (TBP), wheat extract protein extract (WP) and rice 
protein extract (WP). 
Diet group Casein TBP WP RP 




Cornstarch 467 417 440 425 
Lard 50 50 50 50 . 
Sucrose 118 118 118 118 
Cellulose 50 50 50 . 50 
Mineral mix 40 40 40 40 
Vitamin mix 20 20 20 20 
DL-methionine 1 1 1 1 
Cholesterol 1 1 1 1 
Gelatin 20 20 20 20 
I <. 
6 5 
Flavonoids were measured by HPLC according to Choi et al (2007) with 
modification. Briefly, flavonoids were extracted in 80% methanol for 24 hours at 
3 7 T h e ratio of the flour to solvent was 0.5: 30. The mixture was centrifuged, 
the supernatant was filtered through 0.45 |im PVDF membrane and then subjected 
to HPLC analysis (Shimazu, Tokyo, Japan) using a Hypersil ODS C185n column 
(25mmX 0.46, Alltech, Deerfield, Illinois, USA). The mobile phase was solvent A: 
lOmM phosphoric acid; solvent B: methanol. The starting B% was 20% and 
increased to 35% in 10 minutes and then increased to 70% in the following 30 
minutes and kept for 10 minutes. The flow rate was 0.7 ml/min. Rutin and 
quercetin was detected at 320 nm with a UV detector. The retention times were 
about 26.8 and 34.4 min for rutin and quercetin, respectively. 
3.3.3 Determination of plasma lipoproteins 
The analyses were similarly conducted as previously described in section 
2.3.3, Chapter 2. 
3.3.4 Determination of cholesterol concentration in organs and fecal neutral 
and acidic sterols output 
The procedures for determination of organ and fecal neutral and acidic 
sterols were described in section 2.3.4 and 2.3.5, Chapter 2. 
3.3.5 Western blotting of liver SREBP-2, LDLR, HMGR and CYP7A1 
proteins 
The procedures for measurement of protein expression were described in 
section 2.3.4 and 2.3.5, Chapter 2. 
3.3.6 Real-time PGR analysis of mRNA or liver SREBP-2, LDLR, HMGR, 
and CYP7A1 and small intestine NPCILI, ABCG5, ABCG8, ACAT2 and 
MTP 




3.3.7 Intestinal ACAT2 activity measurement 
The ACAT2 activity was measured as described in section 2.3.8，Chapter 2. 
3.3.8 Protein digestibility determination 
Fecal nitrogen content was determined using the Kjeldahl method. The 
apparent digestibility of each protein was calculated using an equation: Apparent 
protein digestibility = (protein intake - fecal protein)/protein intake x lOO. 
3.3.9 Statistics 
Results were presented as means 士 standard deviation (SD). Where 
applicable, one-way analysis of variance (ANOVA) and post hoc LSD test were 
used to statistically evaluate significant differences among the control, buckwheat 
flour, wheat flour and rice flour groups using SPSS (version 16.0, Statistical 
Package for the Social Sciences software, SPSS, Chicago, USA), a, b, c in the 






3.4.1 Diet composition 
Composition in defatted TBP, WP and RP used in the three experimental 
diets were shown in the Table 3.2. The protein contents were 85.69, 70.62, 76.80 
and 72.73% for the casein, TBP, WP and RP extracts, respectively. The lipids in 
casein and RP were a little greater than those in TBP and WP. Quercetin in TBP 
reached 0.97 g/lOOg dry weight while it was not detected in the other two protein 
extracts. It appeared that the protein extraction and de-fat processing did not 
remove the phytosterols. TBP contained most total phytosterols of 67.63 mg/lOOg 
followed by WP (28.18 mg/lOOg) and RP (26.28 mg/lOOg) (Table 3.3). In this 
regard, TBP, WP and RP diets had 19.12, 7.31 and 7.23 mg/lOOg phytosterols, 
respectively. 
Amino acid measurement showed TBP contained more arginine while less 
proline than the other protein extract. The casein contained greater lysine than 
plant protein extracts, thereby a much lower ratio of arginine/lysine than that of 
plant protein extracts. The arginine/lysine ratio in TBP, WP and RP was 2.07, 1.88 
and 2.31, respectively (Table 3.4). 
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Table 3.2 Proximate composition (%) of defatted casein, Tartary buckwheat protein 
extract (TBP), wheat protein extract (WP) and rice protein extract (RP). 
Diet group Moisture Protein Fat Ash TDF 
Casein 9.52 85.69 0.60 0.00 4.19 
TBP 5.33 70.62 0.09 5.96 17.99 
WP 5.62 76.80 0.04 3.39 14.16 




Table 3.3 Phytosterol and quercetin contents in defatted Tartary buckwheat 
protein extract (TBP), wheat protein extract (WP), and rice protein extract (RP) 
(mg/lOQg). 
Diet group TBP WP RP 
P-Sitosterol 59.26 士 0.14 22.56士0. 89 21.99士0.42 
Campesterol 8.36 土 0.10 5.62土 0.01 4.28 士 0.04 
Stigmasterol ND ND ND 
Total phytosterol 67.63 士 0.24 ‘ 28.18±0.90 ‘ 26.28士0.46 ‘ 
Quercetin 917.02 土 9.81 ND ^ 
n 
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Table 3.4 Amino acid composition (%) of defatted casein, Tartary buckwheat 
protein extract (TBP), wheat protein extract (WP), rice protein extract (RP). 
Casein TBP WP RP 
Asp 6.1 5.85 3.05 5.21 
Thr 3.8 1.89 1.93 2.20 
Ser 4.8 2.90 3.35 3.21 
Glu 19.6 11.82 26.21 15.64 
Gly 1.6 3.09 2.74 2.83 
Ala 2.7 2.39 2.53 3.44 
Cys 0.3 2.40 2.81 4.28 . 
Val 6.0 3.43 3.23 5.89 
Met 2.3 1.85 1.18 2.36 
lie 5.0 2.73 3.15 3.26 
Leu 8.0 3.92 5.46 5.85 
Tyr 4.6 1.77 2.45 3.15 
Phe 4.4 3.99 4.17 4.33 
Lys 7.0 2.97 1.39 2.00 
His 2.5 1.59 1.96 1.78 
Arg 3.3 6.16 2.61 4.61 
Pro 9.2 2.48 8.90 4.95 
Arg/Lys ^ 2.07 1.88 2.31 
f 
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3.4.2 Growth, food intake, fecal excretion. 
The body weight and food intake were shown in Table 3.5. Hamsters in TBP 
group had a significantly lower body weight compared with the other groups. 
However, TBP group also consumed lesser food compared with the other groups. 
TBP group had a lower food intake during the first week of feeding probably due 
to the bitter taste of TBP. The food intake was recovered after week 3 in the TBP 
diet group. And there was no difference on the food intake among four groups 
during the entire feeding period. 
Dry fecal weight in TBP group was significantly higher than those in the 
casein and RP groups. No difference was seen between the TBP group and WP 
group (Table 3.5). 
3.4.3 Relative organ weights and organ cholesterol concentration. 
The relative weights of liver, kidney, heart and adipose tissue were shown in 
Table 3.6. The liver weights in the TBP were significantly lower than those of 
the other groups. TBP feeding decreased perirenal fat pad by 38.8% compared 
with casein feeding. A 17.5% reduction in relative weight of epididymal fat pad 
was also observed when TBP was supplemented in diet. 
TBP group had the lowest hepatic cholesterol level followed by RP, WP and 
the control hamsters in an increasing order (Figure 3.1). 
o 
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Table 3.5 Body weight gain and food intake of hamsters fed the casein, Tartary 
buckwheat protein extract (TBP), wheat protein extract (WP), and rice protein 
extract (RP) diets. 
Diet group Casein TBP W P RP 
Initial body 
weight (g) 105.6 土 8.8 102.9 ±8 .1 104.1 土 3.5 103.7 士 5.1 
Final body 
weight (g) 137.2 土 11.6 3 118.0 ± 12.8 b 135.5 ± 1 0 . 4 ^ 142.1 ±18 .2 a 
Bodywt. gain (g) 31.6士 12.4 15.0±9.8 31.4 ± 10.4 38.4土 16.0 . 
Food intake 
(g/lOOg body wt.) 9.62 土 0.60 ^ 8.83 土 0.55 ^ 9.76 土 0.65 ^ 9.96 土 0.53 ^  
Fecal dry weight 
(g/hamster/d) 0‘70±0_10� 1.86±0.43 ^ 1.66±0.65 a’b i .24土0.34 
Values were expressed as mean 土 SD (n=10). Means at the same row differ significantly at 
p<0.05 (a,b,c) ‘ 
I 
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Table 3.6 Relative weights of liver, heart, kidney, epididymal fat, perirenal fat and 
testis of hamsters fed the casein, Tartary buckwheat protein extract (TBP), wheat 
protein extract (WP), and rice protein extract (RP) diets (mg/g). 
Diet group Casein T W W RP 
l i ^ 5.06 土 0.56 a 4 . 1 4 士 0.35 b “ 4 . 6 2 ± 0 . 8 1 ' 4.94 ± 0.59 ‘ 
Heart 0.34 士 0.03 0.35士 0.03 0.33 土 0.02 0.36 士 0.07 
Kidney 0.81 士 0.06 0.84 士 0.04 0.81 士 0.06 0.75 士 0.16 
Testis 1.21 士 0.99 1.29 土 1.31 1.70 土 1.17 1.32 士 0.86 
Epididymal fat 1.66 士 0.39 1.37 士 0.25 1.75 士 0.39 1.86 土 0.31 
Perirenal fat 1.16 士 0.36 a 0.71 土 0.14 b 1.17 士 0.30 a 1.15 士 0.27 a 
Values were expressed as mean 士 SD (n=10). Means at the same row differ significantly at 
p<0.05 (a’b，c) 
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Hepatic cholesterol content (mg/g liver) 
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Figure 3.1 Hepatic cholesterol content in hamsters fed the casein, Tartary 
buckwheat protein extract (TBP), wheat protein extract (WP) and rice prptein 




3.4.4 Effect of different defatted protein extracts on the plasma lipid profile. 
There was no difference in plasma lipoprotein profiles among the four groups 
at week 0 (Table 3.7). At the end of week 3, plasma TC and nHDLC were 
significantly lower in TBP group compared with the control group (p<0.05). Both 
WP and RP were able to lower plasma TC, however, their potency was much 
weaker than TBP. To be specific, TBP diet decreased HDLC significantly 
throughout the experiment while WP diet lowered HDLC level at week 3 not at 
week 6. It appeared that RP diet decreased TC level by lowering nHDLC without 
affecting HDLC. Ratio of nHDLC/HDLC was significantly reduced in the TBP 
group at the end of week 3，however, this effect disappeared at the end of week 6 
(Table 3.7). TBP diet significantly lowered plasma TG level (p<0.05). 
3.4.5 Cholesterol balance and excretion of fecal neutral and acidic sterols. 
Total intake of cholesterol was compared with its excretion as neutral and 
acidic sterols. The apparent cholesterol absorption was calculated by the equation 
[(cholesterol intake-excretion of neutral and acidic sterols)]/cholesterol intake] 
xlOO. 
The acidic sterol excretion in the casein group was decreased gradually with 
the feeding time and was significantly lower than that in the WP and RP groups at 
week 3 and week 6 (Table 3.8). The apparent cholesterol absorption in the casein 
group was gradually increased accompanied with the reduced bile acid excretion. 
TBP diet significantly enhanced excretion of neutral sterols after week 3 
compared with the casein and WP and RP groups. Acidic sterol was significantly 
increased due to supplementation of TBP compared with the casein group and 
increased gradually during the feeding time. Both WP and RP increased the fecal 
sterol output and WP increased neutral sterol mainly while RP increased acidic 
sterol excretion mainly. The net cholesterol intakes were significantly lower in 
WP and RP groups than the casein diet. 
It's noted that the cholesterol output in TBP group was gradually increasing 
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and was 0.27, 1.03 and 2.13 for week 1, week 3 and week 6，respectively. While 
coprostanal, which is a microbial metabolite of cholesterol, was not detected at 
week 3 and week 6 in TBP group (Table 3.9, 3.10 & 3.11). 
3.4.6 Apparent protein digestibility in casein, TBP, WP and RP diet groups. 
There was no difference on the protein intake among the four groups. 
However, fecal excretion of nitrogen in the TBP group was significantly greater 
than that in the casein group followed by RP and WP diet groups with a lesser 
extent. The significant difference was observed among the four groups (p<0.05) 
(Table 3.8). The TBP group had the lowest apparent protein digestibility while the 
casein group had the greatest digestibility among the four groups. The digestibility 
in the RP and WP were intermediate. 
I 
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T a b l e 3 .7 Plasma TC, HDL, nHDLC, the ratio o f n H D L to HDLC and TG in h a m s t e r s f e d 
the casein, Tartary buckwheat protein extract (TBP), wheat protein extract (WP), 
and rice protein extract (RP) diets at week 0, week 3 and week 6. 
Diet group Casein TBP ^ R P 
WeekO 
TC (mg/dL) 109.00士8.08 108.59士9.16 109.87士5.88 103.185士 10.33 
HDLC (mg/dL) 55.24土9.96 52.05土4.06 56.81 土6.12 54.91 士3.02 
nHDLC (mg/dL) 56.22士9.40 56.79士8.80 53.06士9.60 51.16士8.49 
TG (mg/dL) 75.79士25.57 81.67土24.02 81.75士23.75 73.08土21.11 
nHDLC/HDLC 1.03 士0.39 1.09士0.19 0.96士0.23 0.86士 0.16 
HDLC/TC 0.51±0.09 0.50士0.07 0.52士0.07 0.50±0.05 
Weeks 
TC (mg/dL) 268.48土38.68 a 148.47士20.71�225.73土51.69 ‘ 2 4 2 . 2 0士 3 3 . 1 2 a) 
HDLC (mg/dL) 108.52±11.13 ^ 74.56士 3 . 6 1 � 92.24士 11.30' 109.86±11.88 ^ 
nHDLC (mg/dL) 159.94士29.64 a 73.91 土22.21。 132.57士24.76 ‘ 132.34士24.77 ‘ 
TG (mg/dL) 175.42士65.24 a 89.82士29.04 b 143.84±48.80 ‘ 151.13士22.32 ‘ 
nHDLC/HDLC 1.47士0.18 a 1.00士0.33� 1.41 士0.22 a’b 1.20士0.20 b’e 
HDLCATC 0.41 土0.03 b o.51±0.04a 0.42土0.04 b 0.46士0.05 ^山 
Week 6 
TC (mg/dL) 339.28士54.84 a 165.89士29.63� 293.21±35.03 “ 274.82±35.90' 
HDLC (mg/dL) 115.71 士20.98 a 61.99±9.75' 100.82士24.43 a 98.44土 17.22 a 
nHDLC (mg/dL) 217.09士25.65 a 100.00士20.69� 201.05士24.76 a 180.05士25.46 b 
T G (mg/dL) 299.00士 183.62 a 135.76士52.01 b 279.55士68.28 " 250.00士53.58 " 
nHDLC/HDLC 1.80土0.23 b，。 1.61 士0.17 ' 2.20土0.28 a 1.91±0.22' 
HDLC/TC 0.36士0.03 ''' 0.38士0.03 ‘ 0.32士0.03 ^ 0.35士0.03 
Values were expressed as mean 土 SD (n=10). Means at the same row differ significantly at 
；7<0.05 (a,b,c) 
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Table 3.8 Fecal neutral and acidic sterol output in the hamsters fed the casein, 
Tartary buckwheat protein extract (TBP), wheat protein extract (WP), and rice 
protein extract (RP) diets per day at week 1,3 and 6 (mg/hamster/day). 
Diet group Casein TBP W P RP 
week 1 
Neutral sterol 1.23土0.15'' 1.77士0.89 b 2.90土0.70 ‘ 2.90±0.41 ^ 
Acidic sterol 3.39士 1.19 2.02士 1.11 3.67±1.69 4.53士 1.33 
cholesterol intake 9.77士0.79 a 4.35^1.39" 10.78±0.56' 11.40士0.5r 
Cholesterol 
retained 5.51 士 1.25a 0.77 士 0.26 b 4.21 士 1.61 a 4.12±1.57a 
Cholesterol 
retained/intake («/o) 54.34士 11.71 a 18.84±9.32^ 38.83士 13.95 幼 36.63土 13.75 雁山 
week 3 
Neutral sterol 0.71 土0.12 b 1.86±0.69' 3.48±2.43 ‘ 2.01 士 1.29 “山 
Acidic sterol 2.03±I.05b 1.39土0.35 b 3.90土 1.88 “力 6.14士2.95 a 
cholesterol intake 12.54士0.21 ‘ 11.09士0.27 “山 12.00±0.48'''' 10.74士 1.80 b 
Cholesterol 
retained 9.80士 1.12 a 7.16±2.47^ 4.62士0.95 b 2.59土0.42b 
Cholesterol 
retained/intake (%) 78.81 士8.09 ^ 64.22士21.36 ^ 38.34土6.58 ^ 24.99士8.25 ^ 
week 6 
N e u t r a l s t e r o l 0.72士0.25 b 4.50士0.73 a 4.27土0.69 a 3.07士0.73 a 
Acidic sterol 0.81 土 0 . 1 1 � 4.42 士 l .lQa 2.56 土 1.23b 3.01±1.01 a’b 
Cholestero� intake 12.26士0.85 12.42士0.68 12.21 士 1.22 13.01 士 1.10 
Cholesterol 
retained 10.72土 1.03 a 3.14 土 1 . 6 7 � 5.47士 1.26 b’c 6.58士 1.61 匕 
Cholesterol 
retained/intake (%) 87.38士2.80 ^ 28.03 士 12.75 ^ 44.84士 10.49 ^ 51.45土 11.66 ^  
FecalN 
I 
Fecal nitrogen (%) 3.10 ± 0.24 d 6.23土0.17 a 3.28士0.28� 6.07士0.16 b 
Fecal protein(g/d) 0.21 士0.03 d 0.91 士0.15 a 0.36士0.10� 0.60土0.14 b 
Intake of dietary 
protein (g/d) L81±0.13 1.89 士0.10 1.83土0.18 1.95士0.17 
Apparent protein 
digestibility (o/o) 88.17士2.16 a 51.79土7.81 d 80.75士3.98 ^ 69.54±5.27 ^ 




Table 3.9 Fecal neutral and acidic sterol composition in hamsters fed the casein, 
Tartary buckwheat protein extract (TBP), wheat protein extract (WP), and rice 
protein extract (RP) diets at week l(mg/hamster/day). 
Diet group Casein TBP W RP 
Neutral sterols 
Coprostanol 0.50±0.04'' 0.47±0.24^ 0.68士0.22 a � 0.83±0.16^ 
Coprostanone 0.05 士 0.01 0.07 土0.04 0.07士0.02 0.05士 0.02 
Cholesterol 0.17±0.04^ 0.27士0.18 a，b 0.21±0.09^ 0.41 士0.09 a 
Dihydrocholesterol 0.17 士 0.03b o.l5±0.05^ 0.41 士 0.11 ^ 0.39±0.09^ 
Campesterol 0.26士0.06 ^ 0.56士0.30 ^ 1.21 士0.28 ^ 1.02士0.22 ^ 
St igmastero� 0.03士0.01 0.09土0.07 ^ 0.07士0.05 0.01 士0.01 ^ 
Sitosterol 0.06±002 ‘‘ 0.16士0.16 a,b 0.25±0.09 ^ 0.19±0.03 
Total neutral sterol 1.23±0.15^ 1.77±0.89b 2.90±0.70^ 2.90土0.41 a 
Acidic sterols 
Lithocholic acid 1.70土0.65 日山 0.60士0.35 b 1.86士0.81 a 1.66土0.46 a,b 
Deoxychoiic acid 0.86士0.30 b 1.07±0.45^ 1.04土0.46b 2.15士0.35 ^ 
Chenodeoxycholic o.75 士0.27 0.28士 0.11 0.71 土0.43 0.61 士 0.29 
acid + cholic acid 
Ursocholic acid 0.08土0.03 0.06±0.01 ^ 0.06士0.02 b 0.12士0.01 a 
Total acidic sterol 3.39士 1.19 2.02土 1.11 3.67士 1.69 4.53士 1.38 
Values were expressed as mean 士 SD (n=5). Means at the same row differ significantly at 
p<0.05 (a,b,c) 
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Table 3.10 Fecal neutral and acidic sterol composition in hamsters fed the casein, 
Tartary buckwheat protein extract (TBP), wheat protein extract (WP), and rice 
prptein extract (RP) diets at week 3 (mg/hamster/day) 
Diet group Casein TBP W P RP 
Neutral sterols 
Coprostano� 0.21±0.03b ND 0.80±0.61 ^ 0.58士0.38 匕 
Coprostanone 0.07士0.02 a 0.08士0.04 a 0.04土0.03 b 0.01 士0.01 b 
Cholesterol 0.32士0.09 匕 l .03士0.04 ‘ 0.43士0.18 b 0.25士0.16 匕 
D i h y d r o c h o l e s t e r o l 0.09±0.02 “山 0.07士0.02 ^ 0.55土0.50 ‘ 0.34士0.22 “山 
C a m p e s t e r o l 0.02土0.01 b 0.08±0.03 ^ 1.27士0.94 ^ 0.69土0.44 “山 
Stigmasterol ND ND , 0.03士0.03 0.01 土0.01 
Sitosterol ND 0.60士0.27 a 0.36士0.18 b 0.13士0.08 b 
Total neutral sterol 1.23士0.15 b 1.86士0.69 “力 3.48士2.43 a 2.01 ±1.29'''' 
Acidic sterols • 
L i t h o c h o l i c a c i d 1.40土0.75 1.48土 1.25 2.79士 1.55 2.76士 1.27 
Deoxycholic acid 0.14士0.01 0.41 士0.26 0.24士 0.13 1.12士 1:20 
Chenodeoxycholic 
a c i d + choIic acid 0.33土0.19 0.18±0.16^ 0.41 土0.31 ^ 2.15±1.18^ 
Ursocholic acid 0.16±0.10^'^ ND 0.47土0.34 a 0.11士0.10 匕 
Total acidic sterol 2.03士 1.05 ^ . 2.07±1.66'' 3.90士 1.88 山^ 6.19土2.95 a 




Table 3.11 Fecal neutral and acidic sterol composition in hamsters fed the casein, 
Tartary buckwheat protein extract (TBP), wheat protein extract (WP), and rice 
protein extract (RP) diets at week 6 (mg/hamster/day). 
Diet group Casein T1BP W R P 
Neutral sterols 
Coprostano丨 0.37士0.16 b n q 1.01 士0.05 a 0.87士0.28 a 
Coprostanone 0.14±0.04^ 0.34士0.08" 0.05士0.03 b’c 0.01 土0.02� 
Cholesterol 0.14±0.09 b 2.34士0.43 ^ 0.49士0.23 ‘ 0.31 土0.10 ‘ 
Dihydrocholesterol 0.05士0.03。 0.16±0.03^ 0.61±0.05 ‘ 0.50土0.17 “ 
Campesterol 0.02 士 0.01� 0.18 土 0.02"^  1.60 士 0.17" 1.11 士 0.43b 
Stigmasterol ND ND 0.06士0.02 ‘ 0.02士0.02 & 
Sitosterol ND 1.48士0.27 a 0.44士0.22 b 0.18士0.06 b 
Total neutral sterol 0.72士0.25b 4.50士0.73 ' 4.67±0.69' 3.01 士 l .Or 
Acidic sterols 
Lithocholic acid 0.66 士 0.18*' 1.67 士 0.58 b 1.77 士 0.68 b 2.68 士 0.90 ‘ 
Deoxycholic acid 0 .06士0.02 b 2.69士0.61 a 0.74士0.54 b 0.18±0.03^ 
Chenodeoxycholic q.m士0.05 ^ 0.06士0.01 ^ 0.54士0.36 ^ 0.36土0.11 ^ 
acid + cholic acid 
Ursocholic acid 0.01 士0.01 ND 0.01 土0.02 N D 
Total acidic sterol 0.81 士0.09 c 4.42士 1.10 a 3.06士 1.39 b 3.22士0.89 a � 
Values were expressed as mean 土 SD (n=5). Means at the same row differ significantly at 
/7<0.01 (a’b,c) 
8 2 
3.4.7 Effect of different defatted protein extracts on hepatic SREBP-2, 
HMGR, LDLR and CYP7A1 immunoreactive mass. 
The Western Blot analysis showed LDLR protein expression were enhanced 
significantly in the experimental groups compared with control group (Figure 
3.2). 
Real-Time PGR analyses results showed a significantly enhancement on the 
SREBP-2 gene expression in the TBP group. Both WP and RP had a reduced 
HMGR gene expression. RP diet boomed the expression of CYP7A1 compared 
with the other groups. There was no difference on the LDLR expression among 
the four groups (Figure 3.3). 
3.4.8 Effect of different defatted protein extracts on intestinal ABCG5, 
ABCG8，NPCILI, MTP and ACAT2 immunoreactive mass. 
Real-Time analyses demonstrated that TBP diet was associated with 
down-regulation of NPC 1 LI and ABCG8 gene without affectting the expression 
of MTP and ABCG5. On the other hand, WP and RP diets up-regulated the 
expression of MTP and ABCG 5 genes compared with the casein group. No 
significant difference was observed in the intestinal ACAT2 relative gene 
expressions among the groups, although there was a lower trend by 32.5% in the 
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Figure 3.2 Effect of buckwheat flour, wheat and rice flours on the relative 
immunoreactive mass of hepatic sterol regulatory element-bingding protein-2 
(SREBP-2), 3 -hydroxy-3 -methylglutatry-CoA reductase (HMGR), LDL receptor 
(LDLR), and cholesterol-7a-hydroxylase (CYP7A1) as determined by Western 
blot analysis. Data are normalized with (3-actin so that value of the control group 
is regarded as 1.0. Values were expressed as means 士 SD (n=10). 
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Figure 3.3 Effect of casein and defatted Tartaiy buckwheat protein extract (TBP) wheat 
protein extract (WP), rice protein extract (RP) on the relative immunoreactive mass of hepatic 
sterol regulatory element-binding protein-2 (SREBP-2), 3-hydroxy-3-methylglutatry-CoA 
reductase (HMGR), LDL receptor (LDLR), and cholesterol-7a-hydroxylase (CYP7A1) Data 
were normalized with cyclophilin with the value of the control group being regarded as 1.0. 
Values were expressed as means 士 SD (n=10). 
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Figure 3.4 The relative mRNA of intestinal Niemann-Pick CI like 1 (NPCILI), acyl-CoA: cholesterol 
acyltransferase 2 (ACAT2), microsomal triglyceride transfer protein (MTP), and ATP-binding cassette (ABC) 
transporters sub-family G member 5 and 8 (ABCG5/8) in hamsters fed the casein and three experimental 




The present study demonstrated clearly that TBF could favorably modify the 
lipoprotein profile in hamsters fed a high cholesterol diet. In this regard, TBP diet 
group could lower plasma TC by 51.0% compared with the casein group (pO.Ol) 
followed by WP (13.6%) and RP (18.9%) at the end of week 6 (Table 3.7). In 
addition，plasma nHDLC was also significantly reduced in TBP group than that of 
the casein group. WP and RP could also modify the lipoprotein profile similarly to . 
TBP，however, their potency was weaker than TBP. The present results were in 
agreement with those in one previous report showing common buckwheat protein 
could reduce both TC and HDL in hamsters (Tomotake et al 2000). Using rats as 
a model, Tomotake et al (2007) compared the hypolipidemic activity of the 
Tartary buckwheat protein with common buckwheat protein, finding both 
buckwheat species could lower the TC significantly. The present study found that 
plasma HDLC level was not affected in WP and RP diets. This was not consistent 
with a study of Endo et al (2002)，who found HDLC level was reduced by the 
wheat protein. However, the results were supported by several studies reporting 
that rice protein isolate did not affect the HDLC in rats (Sugano et al, 1984; 
Morita et al, 1997; Yang et a!, 2007). 
Hamsters fed a WP diet had a greatest neutral sterol output among the four 
groups, indicating that wheat protein lowered plasma TC through a mechanism of 
increasing fecal sterol excretion. Results were supported by two studies in rats • 
(Bassat and Mokady, 1985; Endo et al, 2002). In contrast, TBP fed hamsters had a 
greater excretion of fecal acidic sterols than WP group. Regarding to RP, the 
increase in total neutral sterol output or acidic sterol output has been documented 
in three studies in other studies (Sugano et al, 1984; Morita et al, 1997; Yang et al, 
2007), however, this effect was not observed in the study conducted by Morita et 
a! (1996), who claimed that the hypochoelsterolemic activity of RP was 
independent of interruption of the enterohepatic circulation of bile acids. However, 
‘ the present results showed RP enhanced both neutral sterol and acidic sterol 
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excretion. Buckwheat protein had also been shown to elevate the acidic sterol 
output in rats and hamsters (Kayashita et al, 1997; Tomotake et al, 2000). Among 
the three proteins, TBP caused a lesser excretion of neutral sterols but a greater 
excretion of the acidic sterols compared with WP and RP (week 6). Interestingly, 
TBP had greater exertion of cholesterol rather than coprostanol. Usually, 
cholesterol is excreted in the stool predominantly in a bacterially modified form, 
coprostanol and coprostanone (Kay, 1981). This phenomenon remained to be 
explored. 
TBP supplementation significantly lowered the hepatic cholesterol level 
followed by RP and WP supplementation. This was attributable to a significant 
up-regulation of SREBP-2 in the TBP group. SREBP-2 regulated transcription 
and expression of HMGR and LDLR (Brown and Goldstein, 1997). High dietary 
cholesterol leads maturation of SREBPs and subsequently inhibits not only 
cholesterol synthesis but also LDLR synthesis, resulting in a high blood 
cholesterol level (Weber et al, 2004). The present study found TBP feeding was 
associated with activation of SREBP-2 with no effect on changes in the 
expression of HMGR or LDLR in the liver, explaining its cholesterol-lowering 
activity. In contrast, HMGR expression was significantly suppressed in WP and 
RP groups. Besides, RP feeding led to a significantly enhanced expression of 
hepatic CYP7A1 and resulted in an increasing synthesis of bile acids. In addition, 
both WP and RP groups had up-regulation of the intestinal ABCG5 mRNA 
expression, indicating that there was much cholesterol efflux back into the 
intestine lumen and excreted in the feces. However, other studies didn't find such 
effect of WP and RP on the hepatic cholesterol levels (Bassat and Mokady, 1985; 
Sugano et al, 1984). Intestinal ACAT2 activity was inhibited by supplementation 
of TBP. 
Dietary amino acid composition was reported to have some effect on plasma 
cholesterol level. Intake of casein has demonstrated to cause hypercholesterolemia 
and atheromatous plaques in animals (Carroll and Hamilton, 1975). It was further 
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shown that there was a negative correlation (r=-0.74) between the serum 
cholesterol level and the Arg/Lys ratio of a dietary protein (Sugano et al, 1984). 
Vshouny et al (1985) reported that a high Arg/Lys ratio in soybean protein was 
responsible for its cholesterol-lowering effect due to a decreased intestinal lipid 
absorption. It was evident when addition of arginine into a casein diet resulted in a 
decreased lipid absorption and vice versa when addition of lysine into a soy 
protein diet. However, this hypothesis was not supported by in a study of Gibney 
(1983). In the present study, Arg/Lys ratio in RP (2.31 w/w), TBP (2.07)，WP . 
(1.88) were much higher than that of casein (0.47), partially explaining the 
relative lower plasma cholesterol levels in the three experimental groups 
compared with the casein hamsters. However, RP with a highest ratio of Arg/Lys 
did not produce a highest cholesterol-lowering acitivity, indicating that the amino 
acid composition was partially responsible and other factors like the phytosterol 
content also had a role in cholesterol-lowering capacity of different protein 
extracts. 
Not only arginine, sulfur-containing amino acids (SAAs) and glysine, were 
reported to be involved in the lipid metabolism (Sugiyama, 1986 and 1997). SSAs 
could contribute greater secretion of VLDL from the liver via the reduction of 
phosphatidylcholine synthesis and thus had a lower plasma cholesterol level. In 
support of this view, Morita et al (1997) indicated that there was a positive 
correlation between serum cholesterol level and dietary methionine concentration 
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or the ratio of Met/Gly in rats fed soy protein and rice protein. Wheat gluten and 
rice protein were reported to lower plasma TC due to their low ratio of Met/Gly 
(Seidd et al, 1960; Morita et al, 1996). The relative availability of SAAs has also 
been proposed as a new index of negative correlation with plasma cholesterol and 
TG levels (Oda, 2006). CYP7A1 was identified as a target gene of 
sulfur-containing amino acids (Oda, 2006). It was proposed that sulflir-containing 
amino acids could enhance CYP7A1 expression via elevated hepatic GSH content 
and resulted in a greater bile acid excretion (Cappel et al, 1988). In the present 
89 
study, the Methionine was added at 0.1% level to each diet group to produce a 
hypercholesterolmic animal model. So it seemed that the hypocholesterolemic 
ability could not be attributed to SSAs content. 
Lower digestibility of buckwheat protein had been claimed to contribute to 
its cholesterol-lowering acitivity (Tomotake et al, 2006). One of the underlying 
mechanisms was that buckwheat protein inhibited the micelle solubility to prevent 
cholesterol absorption in the intestine, thereby leading to a greater fecal sterol 
excretion (Kato and Iwami, 2002). Iwami et al (1986) reported that "hydrophobic" 
peptides were more effective in inhibition on micelle solubility and thus possessed 
a greater cholesterol-lowering potency. "Hydrophobic" property means a higher 
capacity of bile acid-binding. In another word, the less digestive a protein extract 
was the more indigestible and the more un-absorbable peptides it had (Iwami et al, 
1986). The present study demonstrated that a positive correlation existed between 
plasma TC level and protein apparent digestibility of these four proteins (r=0.71), 
while there was an inverse correlation between the fecal sterol output and protein 
apparent digestibility. The data were consistent with the report of Tomotake et al 
(2006), a high buckwheat protein flour had a higher fecal excretion of both neutral 
and acidic sterols. 
Other functional component existing uniquely in TBP may also contribute to 
its cholesterol-lowering activity. Dietary quercetin has been shown to reduce 
serum TC level in animals fed a cholesterol-enriched diet. Supplementation of 
dietary quercetin at 0.2% level was reported to lower TC level in both rats and 
rabbits fed a high cholesterol and high fat diet (Igarashi and Ohmura, 1995; 
Juzwiak et cd, 2005). In the present study, TBP diet contained 0.26% quercetin 
equivalent to 22.9 mg/hamster/day. However, it was very controversial as it was 
also reported addition of quercetin at a level of 100 mg/rat/d resulted in a 
reduction of HDLC while a significant elevation of LDLC with no effect on TC 
level (Yugarani et al, 1992). 
Lastly, phytosterols in grain protein extracts may be also responsible for 
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differences in cholesterol-lowering activity observed for these four proteins. It is 
well known that phytosterols compete with cholesterol for absorption and 
decrease plasma cholesterol level. In this regard, TBP had a highest phytosterol 
level and so plasma TC was lowest. 
3.6 Summary 
TBP was most potent in lowering plasma cholesterol level among the four 
tested protein extracts. TBP could modify the lipoprotein profile by decreasing not . 
only plasma nHDLC but also plasma TG. RP could also lower plasma TC and 
nHDLC levels, however, it had no effect on the HDLC and TG levels. In contrast, 
WP could marginally lower blood TC at week 3 and this effect didn't last to the 
end of feeding. All grain protein extracts reduced the hepatic cholesterol contents 
significantly compared with casein diet with TBP being most potent flowed by RP 
and WP. The cholesterol-lowering activity of TBP was mainly mediated by 
inhibition on the cholesterol absorption in intestine lumen via down-regulation of 
cholesterol transporter NPCILI expression. This is in contrast to WP and RP, 
which reduced the cholesterol synthesis in the liver by suppressing the HMGR 
activity and increasing excretion of fecal sterols. 
In addition, the amino acid composition, the "hydrophobic" peptides, 
phytosterol and quercetion could also be attributable to the varying 






The present study was the first time to explore the hypolipidemic activity of 
Tartary buckwheat flour and its protein extract using a hamster model fed a high 
cholesterol diet compared with casein and wheat flour, rice flour. Further, the 
protein extracts of the three grains were also compared for their hypolipidemic 
ability. 
The results demonstrated that Tartary buckwheat flour could lower plasma 
cholesterol and nHDLC levels as well as hepatic cholesterol content with plasma 
HDLC and TG levels being unaffected. Accordingly, a significantly increasing 
excretion of fecal neutral sterol was observed. The hypolipidemic activity of 
Tartary buckwheat flour was mediated by inhibition of intestinal ACAT2 activity, 
and down-regulation of the intestinal NPCILI mRNA expression, leading to 
greater fecal excretion of cholesterol. Although wheat flour diet and rice flour diet 
had little effect on the body lipid profile compared with casein diet, they could 
also reduce the ratio of the ratio ofnHDLC/HDLC. 
When the protein extracts were given to the hamster, all three kind of 
defatted protein extract showed hypolipidemic activity. Tartary buckwheat protein 
extract was most effective in lowering plasma TC, nHDLC as well as HDLC and 
TG levels. The rice protein extract lowered the plasma TC and nHDLC levels and 
had no effect on the HDLC and TG levels. Wheat gluten can lower blood TC in a 
slight extent at week 3 while this effect didn't last to the end of experiment. All 
protein extract reduced the hepatic cholesterol contents significantly compared 
with casein diet. Similarly, Tartary buckwheat protein extract had the most 
potency to reduce plasma TC followed by rice protein and wheat protein. The 
Tartary buckwheat protein lowered the cholesterol by lowering the cholesterol 
absorption in intestine lumen via down-regulation of NPCILI expression. The 
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wheat protein and rice protein lowered the cholesterol synthesis in the liver by 
suppressing the HGMR activity and increasing excretion of fecal sterol. 
The present study demonstrated that Tartary buckwheat was most 
hypocholesterolemic among the three tested grains. It was concluded that the 
Tartary buckwheat has a great potential to be further developed as a functional 
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